Permissible cyanide discharge limits in industrial effluents.
\r\n\t
",isbn:"978-1-83969-627-5",printIsbn:"978-1-83969-626-8",pdfIsbn:"978-1-83969-628-2",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!0,hash:"f6624b8ef72a4a369383a4b719bba2a4",bookSignature:"Dr. Guillermo Huerta-Cuellar",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/10767.jpg",keywords:"Nonlinear, Materials, Sensors, Applications, Numerical Simulation, Models, Passive-Active Components, Polarization, Birefringence, Lasers, Power, Multistability",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:null,numberOfDimensionsCitations:null,numberOfTotalCitations:null,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"March 3rd 2021",dateEndSecondStepPublish:"March 31st 2021",dateEndThirdStepPublish:"May 30th 2021",dateEndFourthStepPublish:"August 18th 2021",dateEndFifthStepPublish:"October 17th 2021",remainingDaysToSecondStep:"24 days",secondStepPassed:!1,currentStepOfPublishingProcess:2,editedByType:null,kuFlag:!1,biosketch:'Dr. Huerta-Cuellar is a researcher interested in nonlinear dynamical phenomena about real systems, its theoretical-experimental study through numerical simulations, experimental electronic, and optical systems. He is a member of the National System of Researchers Level I and a member of the consolidated research group "Complex Systems, Optics, and Innovation".',coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"237167",title:"Dr.",name:"Guillermo",middleName:null,surname:"Huerta-Cuellar",slug:"guillermo-huerta-cuellar",fullName:"Guillermo Huerta-Cuellar",profilePictureURL:"https://mts.intechopen.com/storage/users/237167/images/system/237167.jpeg",biography:'Dr. Guillermo Huerta-Cuellar completed his doctoral studies at the Research Center in Optics, and a postdoctoral stay at the Potosino Institute of Scientific and Technological Research. He is currently a Tenure Professor-Researcher at the University of Guadalajara, Mexico, has the recognition of the desirable profile PRODEP in the academic context, is a member of the National System of Researchers Level I, and a member of the consolidated research group "Complex Systems, Optics, and Innovation". Dr. Huerta-Cuellar has more than nine years of experience in teaching undergraduate, master, and doctorate students. He has made research stays in Mexico, Italy, Spain, Russia, and the United States of America, and has published 38 indexed articles, 6 book chapters, one book edition, and 12 congress articles. To this date, he has directed and completed 6 theses at the undergraduate level, two at the master level, and one PhD.',institutionString:"University of Guadalajara",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"2",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"University of Guadalajara",institutionURL:null,country:{name:"Mexico"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"11",title:"Engineering",slug:"engineering"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"301331",firstName:"Mia",lastName:"Vulovic",middleName:null,title:"Mrs.",imageUrl:"https://mts.intechopen.com/storage/users/301331/images/8498_n.jpg",email:"mia.v@intechopen.com",biography:"As an Author Service Manager, my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophanides",surname:"Theophile",slug:"theophanides-theophile",fullName:"Theophanides Theophile"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1373",title:"Ionic Liquids",subtitle:"Applications and Perspectives",isOpenForSubmission:!1,hash:"5e9ae5ae9167cde4b344e499a792c41c",slug:"ionic-liquids-applications-and-perspectives",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/1373.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"878",title:"Phytochemicals",subtitle:"A Global Perspective of Their Role in Nutrition and Health",isOpenForSubmission:!1,hash:"ec77671f63975ef2d16192897deb6835",slug:"phytochemicals-a-global-perspective-of-their-role-in-nutrition-and-health",bookSignature:"Venketeshwer Rao",coverURL:"https://cdn.intechopen.com/books/images_new/878.jpg",editedByType:"Edited by",editors:[{id:"82663",title:"Dr.",name:"Venketeshwer",surname:"Rao",slug:"venketeshwer-rao",fullName:"Venketeshwer Rao"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4816",title:"Face Recognition",subtitle:null,isOpenForSubmission:!1,hash:"146063b5359146b7718ea86bad47c8eb",slug:"face_recognition",bookSignature:"Kresimir Delac and Mislav Grgic",coverURL:"https://cdn.intechopen.com/books/images_new/4816.jpg",editedByType:"Edited by",editors:[{id:"528",title:"Dr.",name:"Kresimir",surname:"Delac",slug:"kresimir-delac",fullName:"Kresimir Delac"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3621",title:"Silver Nanoparticles",subtitle:null,isOpenForSubmission:!1,hash:null,slug:"silver-nanoparticles",bookSignature:"David Pozo Perez",coverURL:"https://cdn.intechopen.com/books/images_new/3621.jpg",editedByType:"Edited by",editors:[{id:"6667",title:"Dr.",name:"David",surname:"Pozo",slug:"david-pozo",fullName:"David Pozo"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"52622",title:"Review of the Impact on Water Quality and Treatment Options of Cyanide Used in Gold Ore Processing",doi:"10.5772/65706",slug:"review-of-the-impact-on-water-quality-and-treatment-options-of-cyanide-used-in-gold-ore-processing",body:'\nCyanide is an extremely toxic substance that is produced naturally and artificially. Cyanide has been widely used in several industries applications such as textile, plastics, paints, photography, electroplating, agriculture, metal treatment and mining. The high binding affinity of cyanide for metals such as gold, zinc, copper and silver has enabled it to selectively leach these metals from ores.
\nSouthern Africa is a region rich in minerals such as gold. Countries in the southern Africa boost their economies through vast investments in gold mining. Cyanide leaching has become the dominant gold extraction technology since the 1970s replacing previously used less efficient and more toxic mercury. These gold mines discharge effluent containing toxic cyanides into natural water bodies posing the greatest threat to the quality of water intended for human use. Therefore, it is imperative to develop effective strategies for the removal of cyanide from aqueous industrial wastewater streams.
\nCyanidation is the predominant gold extraction technique since the late nineteenth century. The dissolution of gold in aqueous cyanide is commonly described using Elsner’s equation [1]:
\nGold dissolution is an electrochemical process in which oxygen is reduced at the cathodic zone, while gold is oxidised at anodic regions. The precise overall dissolution of gold in alkaline, aerated cyanide solutions taking place at cathodic and anodic regions is represented in Eqs. (2) and (3).
\nThe main merits of cyanidation are the high selectivity of free cyanide for gold dissolution compared to other metals and an extremely high stability constant (2 × 1038) of the gold cyanide complex [2].
\nDilute sodium cyanide solutions within concentration ranges of 0.01–0.05% are used in mines for gold leaching [3]. Gold ore is subjected to physical processes such as milling, grinding and gravity separation prior to the addition of aqueous sodium cyanide to form slurry. The pH of the resulting extracting solution is increased by adding slaked lime or sodium hydroxide to prevent generation of toxic hydrogen cyanide [4]. The slurry pH is maintained at not less than 10.5 during cyanidation to prevent excessive loss of cyanide by hydrolysis through volatilisation of hydrogen cyanide. Oxygen an important component during cyanidation is continuously pumped into the slurry resulting in the formation of dicyanoaurate (I) complex.
\nSeveral methods are employed for cyanide leaching of gold ore [5]. However, agitation leaching is commonly used for most ores due to its commercial viability [6]. Leaching is typically done in steel vessels, and the solids are maintained in suspension by air or mechanical agitation.
\nThe gold complex NaAu(CN)2 is then extracted from leach solutions by adsorption onto solid adsorbents such as activated carbon or a synthetic ion exchange resin [7–11]. Activated carbon is the most commonly used adsorbent for gold extraction due to several favourable properties such as high adsorption capacity, good reactivation capabilities, low cost, readily available, high mechanical strength and wear resistance [12].
\nGold complexes adsorbed onto activated carbon are eluted to produce concentrated high-grade gold solutions suitable for final gold recovery. Eluents such as sodium hydroxide [13] and organic solvents in aqueous solutions [14] have been used for desorption or stripping of gold from activated carbon.
\nGold is extracted from solution into a concentrated solid form by a process termed recovery. Zinc precipitation [15] and electrowinning [16] have been used to treat concentrated gold solutions produced from activated carbon stripping. Eq. (4) represents the electrochemical reduction process for gold.
\nThe gold recovered from crude undergoes refining to produce crude bullion containing between 90 and 99.5% pure gold [17]. Refining involves roasting the crude gold to convert base metals such as iron, lead, copper and zinc to their respective oxides. This process is then followed by smelting, which removes base oxide impurities in form of slag. The bullion produced can be upgraded further to higher purity platinum group metals by processes such as pyrorefining, hydrorefining and electrorefining [18, 19]. These extraction processes leave behind toxic cyanide tailings.
\nCyanide and related compounds are produced at low levels from plants such as sorghum, cassava, potato, broccoli, cashews and apricots [20]. Cyanide is found in certain bacteria, fungi and algae [21]. Anthropogenic sources of cyanide release also include smoke from cigarettes, automobile exhaust fumes and the production of acrylonitrile. Bulk occurrence of cyanide in the environment is attributed to the human operations in industries, metallurgical and mining activities. Cyanide is mainly produced industrially in form of hydrogen cyanide gas or solid sodium cyanide or potassium cyanide [22].
\nCompounds of cyanides present in water can be generally classified into total cyanide, complex cyanide and free cyanide [23–25]. These aqueous cyanide compounds exist as simple and complex cyanides, cyanates and nitriles. The most toxic form of cyanide is free cyanide, which exists either as cyanide anion or as hydrogen cyanide (HCN) depending on solution pH. HCN is predominant in aqueous systems at pH below 8.5 and can be readily volatilised [26, 27]. At higher pH values, the free cyanide is mainly in form of the cyanide anion. Aqueous cyanides form complexes with metal ions present in industrial wastewaters. These metallo-cyanide complexes exhibit different chemical and biological stabilities. The complexes are classified as weak acid dissociable (WAD) and strong acid dissociable [28, 29] in accordance with the metal-cyanide bond strength. Cadmium, copper, nickel and zinc form weak acid dissociable complexes that readily dissociate under acidic conditions [28]. Complexes of cyanide with cobalt, iron, silver and gold are strong acid dissociable (SAD). Both forms of complexes dissociate and release free cyanide. The stability of these complexes depends on several factors such as pH, light intensity, water temperature and total dissolved solids.
\nCyanide is extremely toxic to humans and aquatic life. Unlike toxic metal ions, the cyanide anion does not accumulate in the body, but instantaneously results in death of aquatic life and human beings in a short time at low dosages through depressing the central nervous system [30]. Cyanide strongly binds cytochromes inhibiting the electron transport chain in mitochondria and energy release in cells [31]. Liquid or gaseous hydrogen cyanide gains entry into the body through inhalation, ingestion or skin absorption. Exposing animals to hydrogen cyanide has several effects such as headaches, dizziness, numbness, tremor and loss of visual sharpness. Other toxic effects of cyanide include an enlarged thyroid gland, cardiovascular and respiratory problems.
\nThere is need for the treatment of wastewater containing cyanide before discharging into the environment to protect water bodies. As a result of this, several countries and environmental bodies have imposed limiting standards for discharging wastewater containing cyanide to main natural water bodies. Table 1 shows the set acceptable discharge limits of total cyanides by different organisations.
\nAgent | \nCyanide limit | \nReference | \n
---|---|---|
The U.S. Environmental Protection Agency (USEPA) | \n50 ppb (aquatic-biota) | \n[32] | \n
\n | 200 ppb (drinking) | \n\n |
India Central Pollution Control Board (CPCB) | \n0.2 mg/L | \n[25] | \n
Mexico | \n0.2 mg/L | \n[33] | \n
Permissible cyanide discharge limits in industrial effluents.
In view of the data outlined in Table 1, strategies aimed at cyanide recovery and removal need to be adopted to maintain concentrations within regulatory limits.
\nVarious cyanide attenuation processes have been successfully implemented in the treatment of industrial effluents. Gold mines in southern Africa have adopted various cyanide attenuation techniques aimed at reducing the toxin level in the tailings to internationally acceptable levels. The common methods of treating cyanide are natural, chemical and biological degradations [34].
\nNatural attenuation reactions occur in cyanide solutions placed in ponds or tailings resulting in the reduction in the cyanide concentration. The dominant natural degradation mechanism is volatilisation of hydrogen cyanide with subsequent atmospheric transformations to less toxic chemicals [34]. Other reactions such as hydrolysis, photolysis, oxidation, complex formation, oxidation to cyanate, thiocyanate formation and precipitation also take place. This natural process occurs with all cyanide solutions exposed to the atmosphere.
\nCyanide forms complexes with metals ions in solution such as zinc, iron and copper. Ferri- and ferrocyanide complexes are extremely stable under most environmental conditions except when exposed to ultraviolet radiation [22]. Zinc and copper cyanide complexes are relatively unstable and can release free cyanide to the environment. Iron cyanide complexes are precipitated by several metals such as Zn, Cu, Ni, Pb, Sn, Cd and Ag over a wide range of pH (2–11). Cyanide and cyanide metal complexes adsorb onto clay, organic matter and oxides of aluminium, manganese and iron. The adsorbed cyanide can be naturally oxidised by oxygen, hydrogen peroxide and ozone into less toxic cyanate. The cyanate is hydrolysed under acidic conditions into ammonium salt and carbon dioxide. Cyanide can be biodegraded to ammonia, which is further oxidised to nitrate [35]. Under anaerobic conditions, HCN is hydrolysed to formic acid or ammonium formate as shown in Eq. (5).
\nElemental sulphur and sulphur containing ores such as chalcopyrite react with cyanide to produce less toxic thiocyanate [36].
\nNatural methods of cyanide attenuation have failed to produce effluents of acceptable quality. This has led to the development of numerous biological, physical and chemical treatment methods [37].
\nAmong the methods used in removing cyanide from wastewater include photocatalysis [38], biotreatment [39], copper-catalysed hydrogen peroxide oxidation [40], ozonation [33], electrolytic decomposition, alkaline chlorination [22], reverse osmosis, thermal hydrolysis and adsorption [41]. Most of these methods have limited applications due to the high cost, production of toxic residues and incomplete degradation of all cyanide complexes [42, 43]. However, biodegradation of aqueous cyanide ions is cheaper than chemical and physical methods [30].
\nThis process was developed by a Canadian company, Inco metal limited, in 1984 [44]. The process makes use of air and sulphur dioxide in the catalytic oxidation of free and complexed cyanide to cyanate [37, 45, 46] as shown in Eq. (6). The process is catalysed by aqueous copper (II) ions under controlled pH of 8–10. The pH is normally maintained by addition of lime.
\nAfter completion of the oxidation process, previously metal ions complexed with cyanide such as Zn+2, Cu+2 and Ni+2 are precipitated as metal hydroxides. This process effectively treats cyanide in slurries and solutions.
\nIn this process, cyanide is oxidised by alkaline chlorine. The process converts all acid dissociable cyanide except for iron cyanide complexes and more stable metal-cyanide complexes. The process is a two-stage process. The first stage involves initial oxidation of free cyanide to cyanogens chloride followed by hydrolysis of cyanogens chloride to cyanate (Eqs. (7) and (8)) at pH 11.
\nDuring the second stage, cyanate is further oxidised to hydrogen carbonate and nitrogen as shown in Eq. (9). The reaction occurs at pH 8.5.
\nThe alkaline chlorination process is primarily applied in the treatment of cyanide solutions rather than slurries, which consume a lot of chorine.
\nOxidation of cyanide tailings by hydrogen peroxide is more suitable for solutions rather than slurries. The oxidation process is maintained at pH of 9–10 to avoid formation of hydrogen cyanide [47]. The oxidation reaction is catalysed by copper (II) sulphate resulting in the production of carbonate and ammonium (Eqs. (10) and (11)).
\nOzone is a superior oxidant to oxygen and has been extensively studied in the oxidation of cyanide [48–51]. Two oxidation mechanisms of cyanide to cyanate by ozone have been proposed, namely simple (Eq. (12)) and catalytic (Eq. (13)).
\nCatalytic ozonation rarely occurs and has only been observed under high acidic conditions. Continued addition of ozone results in the formation of hydrogen carbonate and nitrogen (Eq. (14)).
\nPeroxymonosulphuric acid (H2SO5) or Caro’s acid [52] is used for cyanide treatment in gold tailings. Caro’s acid is prepared in situ by the reaction of hydrogen peroxide with sulphuric acid since it easily decomposes. This acid is mostly used in situations where sulphur dioxide/air cannot be used. Caro’s acid oxidises cyanide to cyanate as shown in Eq. (15).
\nStable cyanide complexes can be precipitated by the addition of complexing agents such as iron. Iron cyanide complexes can coprecipitate other compounds containing cyanide in solution producing solids of cyanide salts. Finely divided insoluble iron sulphide is used for adsorbing free and complexed cyanide in solutions. The adsorption occurs at optimum pH of approximately 7.5. The iron sulphide is prepared from the reaction of iron (II) sulphate and sodium cyanide [53]. If hydrated ferrous sulphate is used, iron (II) cyanide precipitate is produced. Precipitation of iron cyanide occurs at pH between 5 and 6.
\nCyanide tailings can be treated using physical methods such as dilution, membrane and electrowinning.
\nThis is a technique that does not destroy toxic cyanide, but dilute it with an eluent that reduces cyanide concentrations below acceptable discharge limits. Dilution is a cheap simple technique, which is often used as a standalone or in conjunction with other methods as a way of ensuring that discharged effluents are within permissible limits [54]. Dilution is normally an unacceptable method since it does not degrade or reduce the quantity of toxic cyanide exposed to the environment.
\nReverse osmosis and electrodialysis techniques using membranes have been used in extracting cyanide from wastewater. Both techniques have been effectively applied in the removal of free and complexed cyanide [55–57].
\nStrong acid dissociable and weak acid dissociable cyanide complexes can be reduced to metals releasing free cyanide (Eq. (16)) by the application of an electric potential across electrodes immersed in complexes solution. The freed cyanide can then be treated by other processes.
\nFour electrowinning cell designs have been developed for gold processing, namely Zadra, AARL, NIM graphite chip and MINTEK parallel plate cells [54, 58]. Electrowinning performs well in concentrated solutions and has been predominantly utilised for gold processing. This process is termed as Celec or HSA process [59] when it is used for cyanide regeneration.
\nActivated carbon, resins and minerals have been used for cyanide adsorption from solution. Contact vessels such as elutriation columns, agitation cells, packed-bed columns and loops have been used for this purpose. Various separation techniques such as floatation, gravity separation and screening are applied to remove the adsorbed cyanide from solution. The adsorbent is subsequently transferred into another vessel where cyanide is desorbed into low-volume solution, concentrated, reactivated and recycled.
\nResins are typically polymeric beads containing a numerous surface functional groups capable of chelating or ion exchanging. Resins that require a substrate are deposited as thin film, while those that do work without a substrate are mostly used in continuous processes. The first column resin for cyanide recover was developed in 1959 [60]. Metal-cyanide complexes have been reported to adsorb more strongly to resins [61, 62]. The extent of adsorption depends on nature of resin used and how the resin and/or solution is pretreated [63]. Resins are cheaper and more effective than activated carbon since they resist organic fouling, have longer life, desorb faster and regenerate more efficiently [63]. Conventional, commercial strong base resins are most suitable for cyanide recovery since most common cyanide species in gold plant tailings are free cyanide anions within 100–500 mg/L range and the tricyano copper complex, both of which can be extracted directly from pulps using anion exchange resins [22].
\nFree and metal-complexed cyanides are adsorbed by solid wastes, soils and ores containing minerals such as bauxite [AlO.OH/Al(OH)3], ilmenite (FeTiO3), haematite (Fe2O3) and pyrite (FeS2). Mineral groups such as zeolites, clays and feldspars are also effective adsorbents [64, 65].
\nCyanide packed-bed systems can be used to adsorbed cyanide in dilute solutions [30, 66, 67]. Activated carbon has a relatively high affinity for many metal-cyanide complexes, including the soluble cyanide complexes of copper, iron, nickel and zinc [41, 68, 69]. Cyanide is adsorbed at various sites through chelation, ion exchange, solvation and coulombic interactions. This adsorption technique suffers a major drawback of being technically complex and expensive regeneration of activated carbon [70].
\nThe use of microorganisms in the degradation of cyanide in tailing ponds has often been found to be potentially inexpensive and environmentally friendly compared to conventional chemical and physical processes [23, 71, 72]. Enzymatic activities associated with certain species of bacteria, fungi and algae are known to oxidise cyanide to less toxic cyanate [20, 73, 74]. Aerobic and anaerobic passive biological treatment processes are cost-effective alternatives to conventional cyanide treatment strategies since they do not need external energy, chemicals and routine maintenance. However, they suffer limitations such as the need for warmer climates (>10°C), large space and long retention times. Figure 1 shows a flowchart for the aerobic and anaerobic oxidation of cyanides and thiocyanides in gold tailing ponds. Common passive biological treatment processes comprise engineered wetlands containing substrate or a mixture of organic and inorganic compounds like manure, straw, saw dust and limestone [22]. In anaerobic wetlands, bacterial oxidation of cyanides and thiocyanides to sulphates, carbonates and ammonia occurs as illustrated in Eqs. (17) and (18).
\n\nBiological cyanide degradation processes in gold tailings.
The ammonia produced by the aerobic processes provides nutrients for microbial growth and the resultant uptake, sorption, conversion and/or precipitation of cyanides, thiocyanates, sulphates and nitrates by microorganisms [74]. The metals released during the oxidation of cyanide metal complexes are removed from gold tailings by chemical precipitation and/or adsorption on bacterial biofilm. Ammonia also undergoes further oxidation in a two-step nitrification process (Eqs. (19) and (20)).
\nSulphates undergo anaerobic reduction to sulphides (Eq. (21)). This process is effected by sulphate-reducing bacteria [75]. The sulphide produced is precipitated by metal ions resulting in its removal from aqueous tailings.
\nSeveral factors influence the biodegradation of cyanide in gold tailings. The most important environmental factors influencing biological treatment include pH, temperature, oxygen levels and nutrient availability. Enzymes that degrade cyanide are generally produced by mesophilic microorganisms, often isolated from soil, with optimum operating temperatures of between 20 and 40°C [34, 43, 76–79]. The availability of nutrient carbon has been found as a limiting factor in the biodegradation of metal-cyanide complexes [75].
\nHighly acidic and basic conditions have adverse effects on cyanide-degrading microorganisms since bacterial and fungal growth is optimal at pH 6–8 and 4–5, respectively [80]. Cyanide-degrading enzymes have optimum operating pH between 6 and 9. Concentrations of cyanide ions in water or slurries have an impact on the survival and growth of microorganisms. For instance, high cyanide concentrations have been reported to be toxic to Klebsiella oxytoca by damaging the nitrile-degrading enzyme, nitrile hydratase [81].
\nSince the 1990s, research has focused on introducing cyanide treatment technologies aimed at reducing costs and producing environmentally friendly products.
\nCarbon dioxide has been successfully used without a catalyst to replace SO2 as an inexpensive alternative to the SO2/air process [82].
\nWastewater containing free and complexed cyanides can be oxidised by ultraviolet radiation in the presence of a semiconductor catalyst such as titanium dioxide [33]. When the catalyst mixed in the wastewater is exposed to the sunlight, it generates a highly reactive hydroxyl radical oxidant. These radicals initially convert cyanide to cyanate. Photocatalysis partially dissociates ferricyanide and ferrocyanide complexes to free cyanide and iron hydroxide. Photocatalytic oxidation is effective in relatively clear solutions. In the presence of ozone, ultraviolet oxidation does not produce undesirable by-products such as ammonia.
\nSolid or liquid cyanide wastes can be thermally decomposed upon treatment at elevated temperatures and pressure in batch or continuous mode [83]. This process is capable of destroying all cyanide complexes. Cyanide hydrolysis occurs in two steps (Eqs. (22) and (23)) producing ammonia and carbonates.
\nThis cost-effective process was developed in the early 1990s for the treatment of wastes containing high concentrations of cyanide (100,000 mg/L). Thermal reduction reduces cyanide concentration to approximately 25 mg/L, which can be further oxidised by conventional methods such as ozone or hydrogen peroxide to environmentally permissible levels.
\nFree cyanide and cyanide complexes containing waste can be treated by electrochemical oxidation. This is an economical and environmentally friendly technique of destroying cyanide. The process results in cyanide ions being destroyed at the anode as metals are deposited at the cathode [27, 84]. During electrolysis, cyanide is initially oxidised at the anode-producing cyanate ions, which are further decomposed to carbon dioxide and nitrogen gas at the cathode (Eqs. (24) and (25)).
\nThere is a growing use of water as the gold mining activities increase. Water losses should be minimised and recycling adopted as much as possible. Cost-effective and environmentally friendly practices for cyanide treatment need to be implemented. The gold mining industry needs to implement the best practices for cyanide management that are aimed at assisting in protecting human health and reducing environmental impacts through discharge of permissible levels of cyanide in effluents into main water bodies. Such practice will ensure maintenance of good quality of water and sustenance of aquatic life.
\nHaemolytic transfusion reaction (HTR) is the result of accelerated destruction of red blood cells. The most common cause is immunological incompatibility between a donor and a blood recipient. It is mainly haemolysis that is responsible for the destruction of transfused donor blood cells by antibodies present in the recipient, but in rare cases, destruction may be caused in recipient blood cells by donor antibodies present in transfused plasma or platelet concentrate [1]. Haemolysis may also occur due to non-immunological reasons, such as thermal, osmotic or mechanical damage to the transfused blood; bacterial infection or extremely rare and blood transfusion from a donor with congenital haemolytic anaemia due to deficiency of glucose-6-phosphate dehydrogenase [2].
\nCurrently, the incidence of haemolytic transfusion reactions is difficult to estimate. Most data come from retrospective studies that do not include reactions not reported by clinicians. In contrast, prospective studies also contain errors due to reaction symptoms often remaining unrecognised or masked by associated diseases, for example, bleeding or liver disease [1]. The frequency of reporting haemolytic transfusion reactions may also depend on other factors, such as patient population, transfusion response reporting system and medical staff education. Historical research results indicate that the frequency of haemolytic transfusion reactions falls between 1:10,000 and 1:50,000 transfused blood components [3, 4]. In contrast, the incidence for patients receiving a transfusion is estimated to be higher (about 1:500–1:800 patients) because most recipients receive more than one blood unit. It is worth noting that the estimation of the frequency of haemolytic reactions depends on the number of transfusions in a given centre. Thus, in large clinical centres, where severely ill patients are treated, more of these events are recorded [4]. A report issued by the Quebec Haemovigilance System covering 5 years of observation described 47 ABO incompatibility reactions, 55 cases of acute haemolytic transfusion reaction and 91 cases of delayed transfusion reaction in reference to 7059 all reported transfusion reactions. It was estimated that the frequency of reactions resulting from the ABO incompatibility was 1:27,318, acute haemolytic transfusion reactions 1:14,901 and delayed haemolytic transfusion reactions 1:9313 per unit of transfused red blood cell concentrate [5].
\nThe most common reaction among the acute (approximately 30%) was haemolysis resulting from ABO incompatibility [5]. In the annual report Serious Hazards of Transfusion (SHOT), published in England, in 2017, 42 haemolytic transfusion reactions were reported in reference to 3230 of all reactions observed following transfusion of blood components, of which 13 cases of acute haemolytic transfusion reaction and 29 cases of delayed haemolytic reaction (including 6 cases of hyperhemolysis) were reported. The number of reported cases of delayed haemolytic transfusion reaction was higher than in 2016, but comparable with previous years [6]. Factors that can affect the increase in the number of delayed haemolytic reactions include correctness in carrying out serological tests, longer survival of patients after transfusions and an increase in the number of transfused blood components. Since most patients receive more than one unit of red blood cell concentrate, the estimated incidence of delayed haemolytic transfusion reactions is from 1:854 to 1:524 per patient who has been transfused and is higher than per transfused unit [7]. In the population, delayed haemolytic transfusion reactions occur with a frequency of 1.69/100,000 per year [7].
\nRed blood cells undergo haemolysis in the intravascular mechanism, in blood or extravascular vessels, that is, organs involving cells of the reticuloendothelial system, primarily spleen and/or liver. Clinically significant differences between the above mechanisms of red blood cells destruction are based on the time of onset of haemolysis and the destruction rate of red blood cells. Intravascular haemolysis is characterised by the destruction of red blood cells at a rate of about 200 ml of transfused cells within 1 h of transfusion. It is manifested by a rapid decrease in haemoglobin, haemoglobinemia and haemoglobinuria and can potentially be life threatening [2]. In contrast, extravascular haemolysis is less dramatic, with a rate of destruction of red blood cells of approximately 0.25 ml/h/1 kg of recipient’s body weight. For example, for 70 kg recipient, about 18 ml of transfused red blood cells are destroyed per hour. However, it is worth noting that despite the low intensity of haemolysis, the survival time of red blood cells after transfusion is significantly reduced [2]. In general, intravascular haemolysis is called as an early acute haemolytic transfusion reaction. It can occur during transfusion or up to 24 h after transfusion of red blood cells. In comparison extravascular haemolysis is called delayed haemolytic transfusion reaction and usually occurs 24 h or days after the end of the transfusion. The quoted breakdown of reactions is somewhat artificial, because the symptoms associated with haemolytic reactions sometimes overlap [1]. The occurrence and severity of individual clinical symptoms can vary widely and are often non-specific [1, 8].
\nRed blood cell transfusion can also stimulate the production of alloantibodies without the occurrence of haemolysis. This phenomenon is called delayed serologic transfusion reaction (DSTR) and should be differentiated from delayed haemolytic transfusion reaction [9].
\nMost often intravascular haemolysis is the result of the destruction of red blood cells by the complement system, stimulated by the presence of alloantibodies or autoantibodies. Among alloantibodies, such haemolysis is induced by anti-A and anti-B, rarely anti-Jka, anti-Jkb, anti-Vel, anti-P, anti-Lea and very unique antibodies with other specificities [10, 11]. In all these cases, haemolysis takes place via the classical pathway of complement activation. Its occurrence and severity, in addition to the class of antibodies, is also affected by the number of antigenic determinants with which the antibodies react. The reaction is most severe in the case of antigens A and B, because their number is estimated at about 5 × 105 per cell [12, 13]. In contrast, the presence of antigens from the Rh, Kell, Kidd and Duffy systems on the surface of red blood cells is determined in the range of 103–104 per cell [12]. Table 1 shows the number of antigenic determinants on the cell surface for selected red blood cell antigens.
\nBlood group system | \nAntigens | \nThe number of antigenic determinants on the surface of the cell membrane | \n
---|---|---|
ABO | \nA1\n | \n8.5 × 105\n | \n
A2\n | \n2.5 × 105\n | \n|
B | \n7.5 × 105\n | \n|
Rh | \nD | \n1–2 × 105\n | \n
C | \n7–8 × 104\n | \n|
e | \n1.8–2.4 × 104\n | \n|
Kell | \nK | \n6.1 × 103\n | \n
Duffy | \nFya\n | \n1.7 × 104\n | \n
Kidd | \nJka\n | \n1.4 × 105\n | \n
MNSs | \nS | \n1.2 × 104\n | \n
Antibodies combined with antigens by triggering the complement cascade lead to cell lysis. This mechanism is called the classic pathway for complement activation and is shown in Figure 1.
\nThe classic pathway for complement.
The starting point is the antigen-antibody complex present on the surface of the cell membrane [14, 15]. Antibodies of the IgM and IgG class (outside the IgG4 subclass) bind the C1q protein in the initial stage of activation. The condition for complement activation is the binding of the C1q molecule by two Fc fragments of adjacent IgG antibodies or by one IgM molecule. It should be noted here that the IgM class is more efficient in starting the process of complement activation than the IgG class [2, 15]. The C1qrs complex is created and activates the C2 and C4 components and their distribution into C2a and C2b as well as C4a and C4b. The C4b2a complex has proteolytic properties and is called C3 convertase. Convertase breaks down molecules of C3 into C3a, C3b, C3c and C3d. The C3b and C3d components bind with the red blood cell membrane and in many cases the complement cascade process ends. In other cases, the C3b component activates C5 and C5a and C5b are formed. C5b binds to C6, then to C7. This creates a complex of three C5b-6-7 particles, which is partially incorporated into the cell membrane and further binds C8. The C5b-8 complexes create holes in the cell membrane that increase when exposed to the C9 component. The C5B-C9 complex called membrane attack complex (MAC) creates pores in the cell membrane of a red blood cell that are 1/700 of its size. Haemoglobin escapes from the cells into the plasma, and the effects of haemolysis are visible macroscopically in the plasma of the blood sample [15].
\nThe alternative path of complement activation and the lectin path of complement activation do not play a role in the destruction of red blood cells. Although the mechanism of the lectin route may be the reason for the in vivo ineffectiveness of the use of monoclonal and recombinant antibodies, which are thus eliminated from the body before they fulfil their function, for example, anti-D Ig for prevention purposes in RhD maternal-foetal conflict [16].
\nHowever, the complement system does not work specifically. The safety of body cells is enabled by factors that regulate complement activity present in plasma and on cells of various tissues, including red blood cells. Membrane inhibitor of reactive lysis (MIRL) (CD59) and decay accelerating factor (DAF) (CD55) are essential to protect red blood cells from haemolysis. The expression of these membrane inhibitors is associated with Cromer group system and CD59. On blood cells with the Cromer mull phenotype, known as Inab, DAF inhibitor expression is absent [17, 18]. DAF regulates C3a-converting activity. MIRL inhibits membrane attack complex [15, 17]. Lack of these particles may increase the susceptibility of red blood cells to intravascular haemolysis due to complement activation [19].
\nIn a situation in which, despite activation of the complement system, through antigen-antibody reaction, there is no intravascular haemolysis, red blood cells with detectable C3b component remain in the circulation. This kind of mechanism of red blood cell destruction occurs for IgG antibodies with complement system [13]. They may interact with CR1 and CR3 receptors on macrophages and consequently undergo phagocytosis. Most of the cells coated by the complement C3b component are destroyed by liver macrophages, that is, by Kupffer cells, while the cells coated with antibody molecules are mainly destroyed by spleen macrophages. They have surface receptors that recognise antibody classes and subclasses, and complement components, of which the Fc R1 receptor is specific for red cells coated with antibodies [1]. Blood cells connected to this receptor are destroyed in the process of antibody-dependent cytotoxicity. Red blood cells can be absorbed and completely “digested” inside the macrophage. They can also be partially absorbed and then the integrity of the cell membrane is disturbed by the loss of proteins and lipids, which changes its osmotic properties. Such a blood cell, after being released from the macrophage, circulates in the blood as a spherocyte, whose survival is short. The macrophage cytotoxins are another mechanism that plays a role in the destruction of red blood cells. As a consequence of antibody-dependent cell-mediated cytotoxicity (ADCC) haemoglobinemia and haemoglobinuria may occur similarly to intravascular haemolysis, although the antibodies that caused it do not bind complement components.
\nReceptors for complement activation products C3a and C5a are found on many cells: monocytes, macrophages, neutrophils, platelets, endothelium and smooth muscle. Their release causes an increase in the concentration of oxygen radicals, leukotrienes, nitric oxide and cytokines. The increase in cytokine release may also be due to the interaction of Fcγ R1 receptors with IgG molecules associated with red blood cells. Udani et al. [20] showed in vitro that in the case of ABO incompatibility, monocytes are directly involved in the formation of acute haemolytic transfusion reaction [15]. Incompatible red blood cells reduce CD14 expression and increase CD44 expression on monocytes in whole blood. After 24 incubations with incompatible red blood cells, monocytes show a significant increase in CD44 levels. The results of these studies indicate a critical role of monocyte activation in the development of intravascular haemolytic transfusion reaction [15].
\nIn ABO incompatibility, in which anti-A, anti-B and anti-AB antibodies activate complement leading to intravascular haemolysis, a large amount of tumour necrosis factor-α (TNF) and interleukins CXCL8 (IL-8) and CCL2 are released into the plasma (MCP-1) [19, 20, 21]. TNF-α is released first, its elevated concentration is already detected within first 2 h. It carries a pro-inflammatory potential that is responsible for fever, leukocyte activation, stimulation of procoagulant activity, increased antibody production and vascular wall permeability [22]. TNF-α also stimulates endothelial cells to synthesise adhesion molecules and chemotactic cytokines [22]. CXCL8 and CCL2 produced in the blood during ABO incompatibility will appear later than TNF-α in very high concentrations. CXCL8 primarily activates neutrophils, which leads to the accumulation of leukocytes in the lung vessels of small diameter and damage to the endothelium of blood vessels and their higher permeability [1, 12]. CCL2 is mainly a chemotactic and activating factor for monocytes [1, 12].
\nIn incompatibility, in which non-complement IgG antibodies cause extravascular haemolysis, cytokines belonging to two categories differing in response rates are produced: (1) synthesised at a concentration higher than 1 μg/ml within 24 h and (2) synthesised at a concentration of about 100 pg/ml. Low concentration cytokines include IL-1β, IL-6 and TNF-α. CXCL8 concentration is similar to that in intravascular haemolysis, whereas TNF-α is synthesised at low concentration, estimated at <100 pg/ml [1, 2]. IL-1ra (receptor antagonist) is produced in extravascular haemolysis, which is an IL-1 receptor antagonist. Its presence to some extent affects some clinical differences between extravascular and intravascular haemolysis [23]. IL-1β concentration and IL-6 produced by monocytes in response to red blood cells coated with IgG antibodies increase progressively within 24 h to a concentration of 100 pg/ml. Since IL-1β and IL-6 affect proliferation and differentiation of β-lymphocytes, the synthesis of these two cytokines enhances the synthesis of allo- and autoantibodies, which are often involved in the formation of delayed haemolytic transfusion reaction [1, 24, 25].
\nThe key pathogenetic phenomenon in DIC is excessive thrombin generation in the tissue factor (TF)-dependent pathway and activated factor VII (FVIIa-activated factor VII) [26]. In the pathogenesis of DIC, interactions between the blood coagulation system and mediators of the inflammatory response are also of great importance [27]. Proinflammatory cytokines affect blood coagulation and fibrinolysis, for example, TNF-α and IL-1 increase TF expression and inhibit thrombomodulin (TM) expression on vascular endothelial cells [28]. On the one hand, these processes lead to the production of a large amount of thrombin that converts fibrinogen to fibrin. Fibrin creates blood clots in the light of small vessels trapping the platelets. If the activation of coagulation is not timely inhibited, the resulting clots will block the blood supply to vital organs, which will be manifested in their failure. On the other hand, the formation of a large amount of blood clots will “consume” blood coagulation factors and platelets, which will manifest as a haemorrhagic diathesis. In addition, their degradation products (fibrinogen/fibrin degradation products (FDP)) resulting from the breakdown of fibrinogen and fibrin exhibit anticoagulant properties, inhibit platelet function, act as cytotoxic vascular endothelium and increase capillary permeability, further disrupting haemostasis mechanisms [26].
\nClinically, this is manifested by unexpected bleeding and/or a decrease in blood pressure. The course is acute, dynamic, with thrombocytopenia, increased concentration of fibrin degradation products, prolonged prothrombin time (PT), extended partial thromboplastin time after activation (activated partial thromboplastin time (APTT)) and hypofibrinogenaemia. Table 2 presents the point algorithm for the diagnosis of acute disseminated intravascular coagulation.
\nTest | \nResult | \nScore | \n
---|---|---|
Platelet count (×109/l) | \n>100 | \n0 | \n
>50, ale ≤ 100 | \n1 | \n|
≤50 | \n2 | \n|
Concentration of fibrinogen/fibrin degradation markers (FDP; D-dimery) | \nNormal | \n1 | \n
Moderate | \n2 | \n|
Growth significant increase | \n3 | \n|
Prothrombin time extended | \no < 3 s | \n0 | \n
o ≥ 3 s, ale < 6 s | \n1 | \n|
o ≥ 6 s | \n2 | \n|
Fibrinogen concentration (g/l) | \n>1.0 | \n0 | \n
≤1.0 | \n1 | \n|
DIC acute diagnosis | \n≥5 | \n\n |
However, this complication is rare and predominantly accompanies intravascular haemolysis, but in recipients who have received non-compliant blood in the ABO system, it occurs even in 25% of cases [1].
\nHypotension occurs in about 1 in 10 cases of intravascular haemolytic transfusion reaction, but is also sometimes observed in extravascular haemolysis. Complement activation appears to be the most important determining factor in these cases. During the haemolytic reaction, C3a, C4a, C5a and C5a-des-arg anaphylatoxins are released. Furthermore, consumption of a C1-esterase inhibitor contributes to the activation of the kinin pathway associated with the release of bradykinin [32]. In addition, tumour necrosis factor (TNF) and interleukin-1 (IL-1), released by phagocytes during haemolytic transfusion reaction may also contribute to hypotension and shock [32].
\nImpaired renal function is observed in both intravascular and extravascular haemolytic transfusion reactions, although definitely more frequently in the case of intravascular. The severity of this abnormality varies greatly—from asymptomatic increase in urea (BUN) and serum creatinine up to complete anuria. Concomitant hypotension and intravascular coagulation syndrome may increase renal impairment. Blood clots that form in the renal arterioles cause cortical kidney attacks. Haemoglobin released from red blood cells also reacts nephrotoxically with nitric oxide (NO), damaging the epithelial cells of the renal tubules and the stroma that remains after their breakdown [33, 34].
\nIntravascular haemolysis modulates blood pressure and local blood flow through changes in the metabolism of the physiological vasodilator—nitric oxide (NO). NO can bind to thiol groups and haemoglobin haeme [35]. The connection of NO with haeme Fe2+ impairs oxygen transport through Hb. The presence of O2 leads to oxidation of NO to NO3 and oxidation of Fe2+ to Fe3+ and the formation of methaemoglobin. The interaction between Hb and NO is regulated by the allosteric transition of haemoglobin R (oxyHb) to the T form (deoxyHb). In oxyHb, cysteine is exposed at position 93 of the haemoglobin amino acid chain (Cys 93β). It is known that a significant proportion of NO does not immediately bind to HbFe2+ heme, instead it binds to cysteine, resulting in the formation of the S-nitrosothiol derivative Hb (SNO-Hb). This process is reversible, so SNO-Hb releases NO, which is transported to endothelial receptors, where it participates in the regulation of vascular wall tone and blood flow. In the case of haemolysis of red blood cells, the free haemoglobin released from them reacts with NO much faster and more strongly than Hb inside cells [35]. The effect of intravascular haemolysis described above may be very similar to the side effect caused by transfusion of first-generation stromal haemoglobin solutions. This has been tested for its use as a substitute for red blood cells. It had vasoconstrictive and, as a result, hypertensive effect. This effect is largely attributed to the binding nitric oxide by free haemoglobin (NO) [36].
\nIntravascular haemolysis is accompanied by haemoglobinaemia and usually also haemoglobinuria, whereas extravascular haemolysis can only be accompanied by anaemia. In both cases, the patient’s serum bilirubin increases, but it depends on the degree of haemolysis as well as liver function [1]. Elevated LDH is always observed with intravascular haemolysis, not always with extravascular haemolysis. Reduced haptoglobin levels usually occur in both types of haemolysis. Drop in blood pressure is much more common in patients with intravascular than extravascular haemolysis. Renal failure and DIC are also more commonly associated with intravascular haemolysis. Some patients may experience organ failure such as the pancreas, heart and even multiple organ failure that threatens the patient’s life.
\nIn unconscious patients and patients under general anaesthesia, it may be difficult to recognise a haemolytic transfusion reaction, as some symptoms may go unnoticed (e.g. pain and nausea). Pain, which is described as a symptom of haemolytic reactions, is located at the puncture site, back, chest, groin and head. The occurrence of pain in the haemolytic transfusion reaction is not clear. It is probably the result of direct stimulation of nociceptive nerves in perivascular tissue by bradykinin, which, in turn, is released during sudden activation of complement [37]. Clinical manifestations are shown in Table 3.
\nInitial symptoms of haemolytic transfusion reactions | \nComplications | \n
---|---|
Intravascular haemolysis Nausea or vomiting Ache Dyspnoea Decrease in RR and/or tachycardia Dark urine | \nKidney failure Disseminated intravascular coagulation (DIC) | \n
Extravascular haemolysis Fever and/or chills Nausea or vomiting Ache Dyspnoea | \nKidney failure disseminated intravascular coagulation (DIC) | \n
Initial symptoms of haemolytic transfusion reactions.
The most common cause of haemolytic transfusion reactions is the immunological destruction of red blood cells resulting from the reaction of antibodies in the recipient’s blood and the antigens present on the transfused donor’s blood cells to which these antibodies are made.
\nAntibodies capable of destroying transfused blood cells are called clinically relevant antibodies, and the transfusion reaction in the event of immunological incompatibility depends on: (1) specificity of antibodies; (2) thermal amplitude of the antibodies; (3) IgG classes and IgG subclasses; (4) number, density and spatial configuration of antigenic sites on red blood cells; (5) the ability of antibodies to activate the complement system; (6) plasma concentrations of antibodies and (7) volumes of transfused red blood cells. A very important feature of all antibodies responsible for causing a haemolytic transfusion reaction is its in vitro activity at 37°C.
\nAntibodies detected at a lower temperature are not considered clinically relevant, for example, anti-A1, anti-M and anti-P1, whose optimal reaction is usually at low temperature, but if detected at 37°C, they can cause destruction of red blood cells with the appropriate antigen. They then become clinically significant.
\nFeatures of antibodies (specificity, class and heat amplitude) and antigens (density of antigenic sites and their distribution) against which the antibodies directed are interconnected. In different people, antibodies with a particular specificity most often occur in the same class of immunoglobulins and have a similar heat amplitude, for example, anti-A, anti-B and anti-AB from the ABO system often belong to both IgM and IgG classes, they bind complement and have an extended thermal amplitude of up to 37°C.
\nA and B antigens are highly immunogenic. Anti-A, anti-B and anti-AB antibodies are involved in causing an early intravascular transfusion reaction, and transfusion of incompatible blood in the ABO system poses a threat to the recipient’s life, especially when group A red blood cells are transfused to a patient with group O. Sixty-one (61%) of all haemolytic transfusion-related fatal reactions are associated with the ABO incompatibility [38, 39]. A contrasting example is the Lua antigen and anti-Lua antibodies. They are usually IgM molecules, are rarely active at 37°C and usually do not bind complement. Lua antigens have uneven distribution on red blood cells and are weakly immunogenic. No cases of acute haemolytic reaction caused by anti-Lua antibodies have been reported, delayed transfusion haemolytic reaction is rare and occurs only in mild form.
\nNot all detectable alloantibodies that react with red blood cells can cause a haemolytic reaction. The specificity of the antibodies potentially responsible for intravascular and extravascular haemolysis is shown in Table 4.
\nBlood group system | \nIntravascular haemolysis | \nExtravascular haemolysis | \n
---|---|---|
ABO, H | \nAnti-A, -B, -AB, -H in the Bombay phenotype | \n\n |
Rh | \n\n | All | \n
Kell | \nAnti-K | \nAll | \n
Kidd | \nAnti-Jka\n | \nAnti-Jka, -Jkb, -Jk3\n | \n
Duffy | \n\n | Anti-Fya, -Fyb\n | \n
MNS | \n\n | Anti-M, -S, -s, -U | \n
Lutheran | \n\n | Anti-Lub\n | \n
Lewis | \nAnti-Lea\n | \n\n |
Cartwright | \n\n | Anti-Yta\n | \n
Vel | \nAnti-Vel | \n\n |
Colton | \n\n | Anti-Coa\n | \n
Dombrock | \n\n | Anti-Doa, -Dob\n | \n
Specificity of selected antibodies associated with haemolytic transfusion reactions.
Similar reactions to anti-A and anti-B come from anti-PP1Pk, anti-P1 and anti-Vel. Other antibodies cause intravascular haemolysis, but sometimes they may be accompanied by intravascular haemolysis. Such reactions were observed in the following blood group systems: Rh, MNSs, Lutheran, Kell, Duffy, Diego and Lewis. The mechanism of appearance of intravascular symptoms has not been fully explained, because although some of the antibodies bind complement components, their reactions end with C3 components. Only in the case of rare haemolytic reactions due to anti-Lea it was shown that the coated cells are destroyed by the spleen macrophages very slowly and in the event of transfusion of large volumes of red blood cells, they become inefficient. Then intravascular haemolysis coincides with visible haemoglobinuria [40, 41]. Interesting clinical point of view are antibodies from the Kidd system. They activate the complement system to the stage of binding of the C3b component, causing extravascular haemolysis. However, the symptoms in some recipients, or the occurrence of a reaction already during a blood transfusion and haemoglobinuria, indicate that the destruction of blood cells also takes place inside the vessel. In the laboratory setting, anti-Jka antibodies are called “insidious” antibodies because they are often difficult to detect due to their low concentration, and yet they can cause a severe haemolytic complication [41].
\nPatients with antibodies found to be clinically insignificant may theoretically be given a blood transfusion from a donor with the antigen to which they are directed. In clinical practice, however, such antibodies can sometimes destroy donor blood cells. Therefore, if possible, blood without this antigen should be selected [41].
\nAnother cause for haemolytic transfusion reaction may be a secondary immune response in patients who have developed alloantibodies during previous transfusions of blood components or pregnancy. This is called delayed haemolytic transfusion reaction (DHTR) in which current blood transfusion stimulates memory lymphocytes and stimulates the production of alloantibodies directed at incompatible antigen found on transfused blood cells [21, 42]. In approximately 50% of cases, alloantibodies produced after transfusion or pregnancy cease to be detected after a few months, and this period of time depends on the specificity of the antibodies and the individual characteristics of the immune system. Schonewille et al. found that, using current laboratory methods, 25% of red blood cell antibodies become indeterminate on average after about 10 months from production [43]. Therefore, pre-transfusion tests may not always detect the presence of antibodies. Antibodies stimulated for synthesis may cause symptoms of haemolysis after 3–10 days, usually very mild and their presence can be detected after 10–21 days. Table 5 presents features of delayed haemolytic transfusion reaction and the time of their occurrence.
\nTime (days) | \nOccurrence | \nExplanation | \n
---|---|---|
0 | \nNegative pre-transfusion test | \nAntibody titres below detection threshold | \n
1 | \nRed blood cell transfusion | \n\n |
3–10 | \nClinical symptoms of haemolysis | \nAcceleration of transfused blood cells destruction | \n
10–21 | \nPost-transfusion testing of blood samples: DAT and screen of antibodies positive | \nIncrease in antibody titre; donated blood cells coated with antibodies | \n
>21 | \nDAT can be negative | \nDestruction of donor blood cells in reticuloendothelial system and/or liver | \n
>21–300 | \nDAT may be positive, eluate testing may show presence of alloantibodies or panagglutination | \nAlloantibodies not specifically associated with autologous red blood cells or produced warm antibodies | \n
Features of late hemolytic transfusion reaction and time of their occurrence [21].
DAT—direct antiglobulin test.
Antibodies that cause a delayed haemolytic transfusion reaction are IgG molecules that are binding or non-binding for complementary components. Their specificity is most often directed to the antigens of the Rh, Kidd, Duffy, MNS and Kell systems [14]. In approximately 11% of cases, more than one antibody specificity is detected. In rare cases, the result of transfusion alloimmunity in DHTR may be the production of autoantibodies (warm IgG autoantibodies or cold autoagglutinins). This phenomenon occurs in patients with sickle cell disease [44, 45, 46].
\nTransfusion of plasma, platelet or granulocyte concentrate from donors incompatible in the ABO system with the recipient may lead to acute haemolytic transfusion reaction and even death. The severity of the reaction depends on the titre of anti-A and/or anti-B antibodies in the transfused plasma or in the blood component containing the plasma, and on its volume [47, 48, 49]. Tests on the ABO system titre in group O apheresis concentrates of platelets show that 26% of samples have an anti-A or anti-A, B antibody titre of 64 or higher. This concentration may be responsible for causing a haemolytic reaction [50]. In turn, the results of studies by Coolig et al. [51] carried out in pooled platelet concentrates of whole blood groups showed that 60% of them had anti-A titres of at least 64 [51]. Repeated transfusions of ABO incompatible platelet concentrate may lead to accumulation of anti-A antibodies in the recipient’s plasma, which may result in severe haemolytic reactions [52]. Unfortunately, despite many studies, it has not been possible to determine the critical titre of anti-A and/or anti-B antibodies that would be safe in the event of transfusion of ABO incompatible platelet concentrates, and in many countries, proprietary haemolysis prevention programs have been developed for recipients of incompatible platelets [48, 49, 50, 53].
\nHaemolytic transfusion reactions due to passively transferred anti-A and/or anti-B antibodies have also been observed in patients after intravenous immunoglobulin administration [54]. Spath et al. [55] analysed reports available in the literature describing cases of haemolysis in patients treated with intravenous immunoglobulins [55]. They showed that the haemolytic reaction is induced by IgG anti-A/B antibodies present in immunoglobulin products. The reaction generally occurs in high-dose IVIG recipients [55].
\nThe haemolytic transfusion reactions may have a different immunological origin than the reactions of antibodies in the recipient’s blood and the antigen present on the donor’s blood cells. This additional mechanism occurs when recipient’s red blood cells are destroyed by a reaction called “bystander immune cytolysis”. It is defined as the immunological destruction of red blood cells by antibodies whose specificity corresponds to antigens found on other cells/blood cells (e.g. HLA antigens found on leukocytes and plasma proteins), while red blood cells are only close to this immunological “confusion” [56]. They are destroyed by the complement system, although they did not participate directly in the antigen-antibody reaction. One of the reasons for this haemolytic reaction is the binding of the C567 complement complex, activated in an immune reaction, to the membrane of red blood cells not participating in the reaction but located in the vicinity [56]. Blood cells are destroyed as a result of the activation of the binding of the remaining components of C8 and C9 complement and the formation of the MAC complex on the blood cells [56]. The mechanism of “bystander” haemolysis is similar to the destruction of blood cells in patients with paroxysmal nocturnal haemoglobinuria [57, 58]. A characteristic feature of the cell membrane of these blood cells is the lack or weak expression of the CD55 (DAF) and CD 59 (MIRL) proteins, which are complement inhibitors. This makes the subject more susceptible to haemolysis. It was found that when red blood cells became the “bystander” of leukocyte reactions and antibodies directed to them, they underwent haemolysis. The reaction of anti-HLA antibodies with leucocytes caused complement activation, which resulted in haemolysis of the patient’s red blood cells sensitive to the complement [59]. It is noteworthy that in patients with a haemolytic reaction associated with the immune cytolysis of the “bystander” not only transfused red blood cells but also autologous blood cells of the patient were destroyed.
\nEarly haemolytic transfusion reactions should be differentiated with septic shock due to bacterial contamination of the blood component, as well as anaphylaxis and bleeding. In addition, immune haemolysis of nocturnal paroxysmal haemoglobinuria or autoimmune anaemia should also be considered. The cause of an early haemolytic reaction may also be congenital haemolytic anaemia, for example, glucose-6-phosphate dehydrogenase deficiency or microangiopathic haemolytic anaemia (TTP, HUS and HELLP). In differential diagnosis, attention should also be paid to non-immune reasons related to improper blood storage, transfusion of red blood cells through a small needle diameter, etc.
\nDifferential diagnosis of delayed haemolytic transfusion reactions includes latent sources of infection, autoimmune haemolytic anaemia, cold agglutinin disease, nocturnal paroxysmal haemoglobinuria, bleeding, mechanical destruction of red blood cells, for example, artificial heart valves and TTP.
\nIt should be noted that an increase in body temperature and white blood cell count, typical for DHTR, can be interpreted as a sign of infection. In some patient groups, it may be difficult to recognise a delayed haemolytic transfusion reaction. Patients with liver failure are a special problem. Haemoglobinemia is not diagnosed in the serum of these patients due to jaundice, often direct antiglobulin reaction (DTA) is positive and elevated bilirubin and LDH are found.
\nAnother group are patients with absorbing haematomas. They may be similar to delayed haemolytic reactions. Elevated unbound bilirubin, LDH and decreased haptoglobin are observed. The presence of fibrinogen degradation products from an absorbing haematoma can be interpreted as a DIC symptom. DHTR can be identified in these patients by the presence of antigen on the transfused red blood cells to which the antibodies may be directed. Table 6 presents the differential diagnosis of haemolytic transfusion reactions.
\n\n
| \n
Differential diagnosis of haemolytic transfusion reactions [1].
If a haemolytic transfusion reaction is suspected, medical personnel should immediately stop transfusing a blood component. The blood unit should be checked at the patient’s bedside, whether it was properly administered. Often, the clinical manifestations of haemolytic reactions are not clear, and the cause of the complication should be differentiated with bacterial infection. Therefore, prior to conducting laboratory tests of donor blood, bacteriological examination of the component remaining after the transfusion cessation should be conducted.
\nLaboratory tests—mainly serological—are crucial for the diagnosis of an early haemolytic reaction. The type of laboratory tests performed for early transfusion haemolytic reactions is shown in Table 7.
\nBlood product | \nConfirm ABO, Rh Confirm other antigen types, if indicated | \n
Blood bank laboratory | \nDirect antiglobulin test (DAT) Confirm ABO, RH, antibody screen and identification Post-transfusion haemolysis check | \n
Clinical laboratory | \nComplete blood count, platelet count Urinalysis for haemoglobin Serum bilirubin, creatinine, urine quantitation, coagulation profile DIC evaluation | \n
Type of laboratory tests and the location of their performance in the case of early transfusion reaction.
The basic serological examination consists of direct antiglobulin testing (DAT); determination of blood group and RhD in donor and recipient; repetition of the serological compliance test. A test should be performed for the presence of antibodies in the recipient before and after the transfusion. Positive DAT indicates haemolysis of red blood cells of immunisation origin. A negative DAT result does not exclude haemolysis, it may mean that the transfused blood cells have been destroyed by alloantibodies or the method used is not very sensitive. Alvarez et al. [60] compared the sensitivity of DAT performed by technique using monospecific IgG antiglobulin, flow cytometry and antibody elution. The study showed that DAT could only indicate 10% of antibody coated cells [61]. Performing DAT in the red blood cell eluate, its sensitivity was 1%. Flow cytometry proved to be a similarly sensitive method.
\nThe re-determination of the ABO and RhD blood group of the recipient before and after the transfusion and in the donors’ blood will exclude errors in the identification of the recipient or blood sample (wrong blood in tube (WBIT)). Test results carried out by Biomedical Excellence for Safer Transfusion Working Party of The International Society for Blood Transfusion in 10 countries with 62 institutions, which examined a total of 690,000 blood samples, showed that the frequency of WBIT is 1 in 165. In two countries, Sweden and Finland, which have implemented national identification systems, this frequency was 1 for 1986 samples [61].
\nAll-antibody screening for recipients is generally performed using routine testing on standard blood cells. A panel of standard cells should contain clinically important antigens in a homozygous form to detect the presence of weak antibodies. The test should be performed on serum/plasma samples taken before and after transfusion. If positive results indicate alloantibodies are present, they should be identified. Detection of a specific antigen on the donor’s blood cells is the confirmation that the detected alloantibodies were responsible for the haemolytic transfusion reaction. If negative results are obtained, additional tests should be performed, for example, PTA PEG, polybrene test and PTA NaCl test. If negative results persist, the test should be repeated after a week and after 2 weeks, as in some patients, the antibodies may have been consumed to destroy transfused incompatible red blood cells.
\nLaboratory tests that help to differentiate haemolysis include determination of free haemoglobin in the blood and urine, haptoglobin and lactate dehydrogenase (LDH) and bilirubin. While interpreting the obtained test results, it should be kept in mind that haemolysis or shortening the survival time of red blood cells can be caused by non-immunological factors, for example, adding hypotonic fluids to red blood cells, inefficient heating or freezing devices, etc. [62]. Table 8 presents changes in laboratory indicators in transfusion haemolytic reactions [56].
\nLaboratory indicators | \nFrequency (%) | \n
---|---|
Low haptoglobin 92 | \n92 | \n
Positive DAT | \n89\n*\n\n | \n
Increased bilirubin concentration medium/slow | \n80 | \n
The presence of haemoglobin in plasma and/or urine | \n88 vs. 52\n**\n\n | \n
Changes in laboratory indicators in haemolytic transfusion reactions [56].
Negative DAT mainly associated with HTR in ABO incompatibility.
IHTR vs. DHTR.
Laboratory tests show anaemia, increased LDH and bilirubin, decreased haptoglobin and higher white blood cell counts in post-transfusion haemolytic reactions. Bilirubin concentration depends on the severity of haemolysis and liver function.
\nSerological tests show positive DAT and the presence of all red blood cell antibodies that were not detected prior to transfusion. This means that after transfusion of red blood cells, the production of alloantibodies directed to the antigen found on the transfused blood cells occurs.
\nPositive DAT with anti-IgG reagents or with anti-IgG and anti-C3 reagents is generally seen as two red blood cell populations. It has been observed that in some patients, the coating of blood cells includes not only transfused, but also autologous red blood cells. Positive DAT with anti-IgG and anti-C3d reagents may persist for several months [9].
\nAlloantibody testing should be performed in the intermediate antiglobulin test (IAT) and enzyme test. In both methods, in addition to the reference blood cells, the patient’s autologous blood cells should be included. Depending on the specificity, alloantibodies responsible for the delayed transfusion reaction activate in characteristic tests, for example, antibodies from the Rh system react in an enzymatic test, often also in anti-globulin testing. In contrast, anti-K, anti-Fya antibodies react in an anti-globulin test. Positive reactions with allogeneic blood cells are accompanied by positive auto control of the patient’s red blood cells. Ness et al. [9] showed that the formation of warm autoantibodies after the onset of DHTR is relatively common. Approximately one-third of patients who were examined 25 days after the onset of the reaction presented a positive DAT due to autoantibodies with broad specificity [9]. The incidence of autoantibodies after DHTR may be even higher because autoantibodies may mimic the specificity of alloantibodies.
\nUsually, plasma alloantibodies are detectable at 4–7 days after the transfusion and reach maximum activity between 10 and 15 days after the transfusion. When examining recipient red blood cells using a diagnostic reagent with a specificity corresponding to alloantibodies detected in the patient, mixed agglutination is observed, which indicates the presence of two blood cell populations in the patient’s circulation. One of them, which does not react with diagnostic antibodies, is the recipient’s autologous blood cells, the other population is antigenically incompatible transfused donor cells, not yet removed from the recipient’s circulation.
\nTreatment of early haemolytic transfusion reactions depends mainly on the patient’s condition, which must be closely monitored. It is most important to observe the clinical symptoms of the recipient and stop the blood transfusion at the right moment. Particular attention should be paid to the patient’s circulation. In the event of a marked decrease in blood pressure, make-up fluids should be transfused and pressure amines should be administered. However, it is important to avoid overloading the circulation with fluids, especially in patients with heart or kidney failure. Catheterisation of the pulmonary artery helps to monitor the situation.
\nIn some cases, an exchange transfusion should be considered, bearing in mind that the haemolysis intensity depends mainly on the volume of incompatible blood transfused. For exchange transfusion, red blood cells without an antigen should be used against which the patient has developed alloantibodies. The decision to carry it out must be balanced and the course carefully monitored. It should be emphasised that in patients with an early reaction due to ABO incompatibility, exchange transfusion may reduce the risk of serious complications or death. For patients with ongoing haemorrhage choosing a blood for transfusion may be difficult. However, it should be remembered that these difficulties must not cause risk of haemorrhage. Often the way out of this situation is transfusion of O RhD negative red blood cells.
\nThe prevention of renal failure is aided by an early prevention of hypotension. A fluid balance should be maintained, the use of dehydrating agents (mannitol and furosemide) is helpful, but their oliguria should be closely monitored. Low doses of dopamine (1–5 μg/kg/min) may be used to maintain renal circulation, but this may not be effective.
\nTreatment and prevention of DIC during haemolytic transfusion reaction is controversial. Heparin is recommended because it additionally acts as an inhibitor of the complement activity and limits haemolysis. However, there is a danger of bleeding. Another method of treating early haemolytic transfusion reaction is to use a high dose of 0.4/kg intravenous immunoglobulin per 24 h after blood transfusion.
\nDelayed haemolytic transfusion reactions are well tolerated by most patients. Additional fluid and diuretic therapy are usually not necessary. Depending on the severity of the anaemia, transfusion of blood components should be avoided until the antibodies responsible for the reaction have been identified and the appropriate selection of blood cells has been made. Attempts have been made to use high doses of intravenous immunoglobulins to prevent haemolytic reactions in patients who have been immunised for winter and for whom compatible red blood cells have not been selected [63]. The main procedure for subsequent transfusions is to select red cells that do not contain the antigen for which all antibodies have been detected. Table 9 summarises the treatment options used in haemolytic transfusion reactions.
\nTherapeutic intervention | \nIndication | \nTypical dose | \n
---|---|---|
Hydration | \nPrevent renal impairment Maintain urine output >100 ml/h | \nNormal saline and/or 5% dextrose 200 ml/m2/h | \n
Alkalinisation of urine | \nPrevent renal impairment Maintain urine pH > 7.5 | \nNaH2CO3 40–70 mEq | \n
Diuresis | \nPrevent renal impairment | \nMannitol 20% 100 ml/m2\n Furosemide 40–80 mg | \n
Vasodilation | \nIncrease renal blood flow | \nDopamine 1–5 μg/kg/min | \n
Anticoagulant | \nTreat DIC | \nHeparin 5–10 u/kg/h | \n
Red cells exchange transfusion | \nDecrease load of incompatible red cells | \nExchange of one estimated red cells mass | \n
Plasma or platelet transfusion | \nTreat haemorrhagic complications of DIC | \nPlatelet—1 unit platelet/10 kg or 1 unit apheresis platelet FFP—10 ml/kg | \n
Intravenous immunoglobulin (not standard therapy) | \nPrevent extravascular haemolysis | \n0.4 mg/kg | \n
Therapeutic options in haemolytic transfusion reactions [1].
DIC—disseminated intravascular coagulation; FFP—fresh frozen plasma.
Data on the incidence of haemolytic transfusion reactions vary from country to country and change over time. There are several causes. One of them was the use of improved techniques for detecting clinically relevant alloantibodies, which reduce the number of haemolytic transfusion reactions observed in blood recipients. In addition, the widespread introduction of automation and computerisation to pre-transfusion studies, which significantly limits the possibility of errors in serology laboratories and blood banks.
\nThe above improvements, however, did not significantly affect the elimination of mistakes made in hospitals leading to transfusion of inappropriate blood to the patient. These include, among others, errors in collecting blood samples from patients and blood transfusions to a wrong patient. These errors are the most common cause of ABO incompatible transfusions, threatening the patient’s life.
\nThe introduction of haemovigilance transfusiological surveillance systems has enabled the analysis of all fatal and severe transfusion reactions. It allows to identify malfunctioning procedures leading to transfusion reactions. It enforces the introduction of procedures eliminating further errors.
\nPreventing haemolytic transfusion reactions by focusing on advances in serology and transfusion medicine has significantly reduced their incidence. Progress in understanding reaction pathophysiology has helped clinically assess patients and treat them effectively. It is possible that technological progress enabling modification of red blood cells and the use of red blood cell substitutes will significantly change transfusion practice in the future and eliminate the occurrence of haemolytic transfusion reactions. But until then, HTRs will remain the most important adverse post-transfusion reaction.
\nIntechOpen Compacts provide a mid-length publishing format which bridges the gap between journal articles, book chapters and monographs, and cover content across all scientific disciplines. Compacts are the preferred publishing option for brief research reports on new topics, in-depth case studies, dissertations, or essays exploring new ideas, issues or broader topics on the research subject.
",metaTitle:"IntechOpen Compacts",metaDescription:"IntechOpen Compacts present a mid-length publishing format which bridges the gap between journal articles, book chapters, and monographs and covers content across all scientific disciplines.",metaKeywords:null,canonicalURL:"/page/compacts",contentRaw:'[{"type":"htmlEditorComponent","content":"Without sacrificing the quality of carefully edited and produced peer-reviewed content, Compacts are published as part of IntechOpen’s book collection but on a faster schedule, typically 4-6 weeks after acceptance. With an average of 132,000 visitors per week, publishing in Compacts not only guarantees high visibility but also facilitates international content sharing. As a fully Open Access publisher, the utilization of a CC BY NC 4.0 license means that other researchers will never have to pay permission fees and can adapt, use, and further build upon the material published in Compacts, eliminating any barriers to the further development of scientific research.
\\n\\nCOMPACTS-SHORT FORM MONOGRAPH
\\n\\nCOST
\\n\\n4,000 GBP Compacts Monograph - Short Form
\\n\\nThe final price will depend on the volume of the publication and includes project management, editorial and peer-review services, technical editing, language copyediting, cover design, book layout, book promotion and ISBN assignment.
\\n\\n*The price does not include Value-Added Tax (VAT). Residents of European Union countries need to add VAT based on the specific rate applicable in their country of residence. Institutions and companies registered as VAT taxable entities in their own EU member state will not pay VAT by providing us with their VAT registration number. This is made possible by the EU reverse charge method.
\\n\\nOptional Services
\\n\\nIntechOpen has collaborated with Enago, through its sister company, Ulatus – one of the world’s leading providers of book translation services. The services are designed to convey the essence of your work seamlessly to readers from across the globe in their own language. Enago’s expert translators incorporate cultural nuances in translations to make the content relevant for local audiences while retaining the original meaning and style. With a high degree of linguistic and subject expertise, Enago translators are equipped to handle all complex and multiple overlapping themes encompassed in a single book to deliver a superior quality of translation.
\\n\\nIntechOpen Authors that wish to use this service will receive a 20% discount on all translation work. For more information or a quote, please visit: https://www.enago.com/intech.
\\n\\nFUNDING
\\n\\nWe feel that financial barriers should never prevent researchers from publishing their research. Please consult our Open Access Funding page to explore funding opportunities and learn more about how you can finance your IntechOpen publication.
\\n\\nBENEFITS
\\n\\nPUBLISHING PROCESS STEPS
\\n\\nSee a complete overview and description of the steps involved in the publishing process here.
\\n\\nSEND YOUR PROPOSAL
\\n\\nIf you are interested in publishing your book with IntechOpen, please submit your book proposal by completing the Publishing Proposal Form.
\\n\\nNot sure if this is the right option for you? Please refer back to the main Publish with IntechOpen page or feel free to contact us directly at book.department@intechopen.com
\\n"}]'},components:[{type:"htmlEditorComponent",content:'Without sacrificing the quality of carefully edited and produced peer-reviewed content, Compacts are published as part of IntechOpen’s book collection but on a faster schedule, typically 4-6 weeks after acceptance. With an average of 132,000 visitors per week, publishing in Compacts not only guarantees high visibility but also facilitates international content sharing. As a fully Open Access publisher, the utilization of a CC BY NC 4.0 license means that other researchers will never have to pay permission fees and can adapt, use, and further build upon the material published in Compacts, eliminating any barriers to the further development of scientific research.
\n\nCOMPACTS-SHORT FORM MONOGRAPH
\n\nCOST
\n\n4,000 GBP Compacts Monograph - Short Form
\n\nThe final price will depend on the volume of the publication and includes project management, editorial and peer-review services, technical editing, language copyediting, cover design, book layout, book promotion and ISBN assignment.
\n\n*The price does not include Value-Added Tax (VAT). Residents of European Union countries need to add VAT based on the specific rate applicable in their country of residence. Institutions and companies registered as VAT taxable entities in their own EU member state will not pay VAT by providing us with their VAT registration number. This is made possible by the EU reverse charge method.
\n\nOptional Services
\n\nIntechOpen has collaborated with Enago, through its sister company, Ulatus – one of the world’s leading providers of book translation services. The services are designed to convey the essence of your work seamlessly to readers from across the globe in their own language. Enago’s expert translators incorporate cultural nuances in translations to make the content relevant for local audiences while retaining the original meaning and style. With a high degree of linguistic and subject expertise, Enago translators are equipped to handle all complex and multiple overlapping themes encompassed in a single book to deliver a superior quality of translation.
\n\nIntechOpen Authors that wish to use this service will receive a 20% discount on all translation work. For more information or a quote, please visit: https://www.enago.com/intech.
\n\nFUNDING
\n\nWe feel that financial barriers should never prevent researchers from publishing their research. Please consult our Open Access Funding page to explore funding opportunities and learn more about how you can finance your IntechOpen publication.
\n\nBENEFITS
\n\nPUBLISHING PROCESS STEPS
\n\nSee a complete overview and description of the steps involved in the publishing process here.
\n\nSEND YOUR PROPOSAL
\n\nIf you are interested in publishing your book with IntechOpen, please submit your book proposal by completing the Publishing Proposal Form.
\n\nNot sure if this is the right option for you? Please refer back to the main Publish with IntechOpen page or feel free to contact us directly at book.department@intechopen.com
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{sort:"featured,name"},profiles:[{id:"6700",title:"Dr.",name:"Abbass A.",middleName:null,surname:"Hashim",slug:"abbass-a.-hashim",fullName:"Abbass A. Hashim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/6700/images/1864_n.jpg",biography:"Currently I am carrying out research in several areas of interest, mainly covering work on chemical and bio-sensors, semiconductor thin film device fabrication and characterisation.\nAt the moment I have very strong interest in radiation environmental pollution and bacteriology treatment. The teams of researchers are working very hard to bring novel results in this field. I am also a member of the team in charge for the supervision of Ph.D. students in the fields of development of silicon based planar waveguide sensor devices, study of inelastic electron tunnelling in planar tunnelling nanostructures for sensing applications and development of organotellurium(IV) compounds for semiconductor applications. I am a specialist in data analysis techniques and nanosurface structure. I have served as the editor for many books, been a member of the editorial board in science journals, have published many papers and hold many patents.",institutionString:null,institution:{name:"Sheffield Hallam University",country:{name:"United Kingdom"}}},{id:"54525",title:"Prof.",name:"Abdul Latif",middleName:null,surname:"Ahmad",slug:"abdul-latif-ahmad",fullName:"Abdul Latif Ahmad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"20567",title:"Prof.",name:"Ado",middleName:null,surname:"Jorio",slug:"ado-jorio",fullName:"Ado Jorio",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Federal de Minas Gerais",country:{name:"Brazil"}}},{id:"47940",title:"Dr.",name:"Alberto",middleName:null,surname:"Mantovani",slug:"alberto-mantovani",fullName:"Alberto Mantovani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"12392",title:"Mr.",name:"Alex",middleName:null,surname:"Lazinica",slug:"alex-lazinica",fullName:"Alex Lazinica",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12392/images/7282_n.png",biography:"Alex Lazinica is the founder and CEO of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his PhD studies in Robotics at the Vienna University of Technology. Here he worked as a robotic researcher with the university's Intelligent Manufacturing Systems Group as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and most importantly he co-founded and built the International Journal of Advanced Robotic Systems- world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career, since it was a pathway to founding IntechOpen - Open Access publisher focused on addressing academic researchers needs. Alex is a personification of IntechOpen key values being trusted, open and entrepreneurial. Today his focus is on defining the growth and development strategy for the company.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"19816",title:"Prof.",name:"Alexander",middleName:null,surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/19816/images/1607_n.jpg",biography:"Alexander I. Kokorin: born: 1947, Moscow; DSc., PhD; Principal Research Fellow (Research Professor) of Department of Kinetics and Catalysis, N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, Moscow.\r\nArea of research interests: physical chemistry of complex-organized molecular and nanosized systems, including polymer-metal complexes; the surface of doped oxide semiconductors. He is an expert in structural, absorptive, catalytic and photocatalytic properties, in structural organization and dynamic features of ionic liquids, in magnetic interactions between paramagnetic centers. The author or co-author of 3 books, over 200 articles and reviews in scientific journals and books. He is an actual member of the International EPR/ESR Society, European Society on Quantum Solar Energy Conversion, Moscow House of Scientists, of the Board of Moscow Physical Society.",institutionString:null,institution:{name:"Semenov Institute of Chemical Physics",country:{name:"Russia"}}},{id:"62389",title:"PhD.",name:"Ali Demir",middleName:null,surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62389/images/3413_n.jpg",biography:"Dr. Ali Demir Sezer has a Ph.D. from Pharmaceutical Biotechnology at the Faculty of Pharmacy, University of Marmara (Turkey). He is the member of many Pharmaceutical Associations and acts as a reviewer of scientific journals and European projects under different research areas such as: drug delivery systems, nanotechnology and pharmaceutical biotechnology. Dr. Sezer is the author of many scientific publications in peer-reviewed journals and poster communications. Focus of his research activity is drug delivery, physico-chemical characterization and biological evaluation of biopolymers micro and nanoparticles as modified drug delivery system, and colloidal drug carriers (liposomes, nanoparticles etc.).",institutionString:null,institution:{name:"Marmara University",country:{name:"Turkey"}}},{id:"61051",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"100762",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"St David's Medical Center",country:{name:"United States of America"}}},{id:"107416",title:"Dr.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Texas Cardiac Arrhythmia",country:{name:"United States of America"}}},{id:"64434",title:"Dr.",name:"Angkoon",middleName:null,surname:"Phinyomark",slug:"angkoon-phinyomark",fullName:"Angkoon Phinyomark",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/64434/images/2619_n.jpg",biography:"My name is Angkoon Phinyomark. I received a B.Eng. degree in Computer Engineering with First Class Honors in 2008 from Prince of Songkla University, Songkhla, Thailand, where I received a Ph.D. degree in Electrical Engineering. My research interests are primarily in the area of biomedical signal processing and classification notably EMG (electromyography signal), EOG (electrooculography signal), and EEG (electroencephalography signal), image analysis notably breast cancer analysis and optical coherence tomography, and rehabilitation engineering. I became a student member of IEEE in 2008. During October 2011-March 2012, I had worked at School of Computer Science and Electronic Engineering, University of Essex, Colchester, Essex, United Kingdom. In addition, during a B.Eng. I had been a visiting research student at Faculty of Computer Science, University of Murcia, Murcia, Spain for three months.\n\nI have published over 40 papers during 5 years in refereed journals, books, and conference proceedings in the areas of electro-physiological signals processing and classification, notably EMG and EOG signals, fractal analysis, wavelet analysis, texture analysis, feature extraction and machine learning algorithms, and assistive and rehabilitative devices. I have several computer programming language certificates, i.e. Sun Certified Programmer for the Java 2 Platform 1.4 (SCJP), Microsoft Certified Professional Developer, Web Developer (MCPD), Microsoft Certified Technology Specialist, .NET Framework 2.0 Web (MCTS). I am a Reviewer for several refereed journals and international conferences, such as IEEE Transactions on Biomedical Engineering, IEEE Transactions on Industrial Electronics, Optic Letters, Measurement Science Review, and also a member of the International Advisory Committee for 2012 IEEE Business Engineering and Industrial Applications and 2012 IEEE Symposium on Business, Engineering and Industrial Applications.",institutionString:null,institution:{name:"Joseph Fourier University",country:{name:"France"}}},{id:"55578",title:"Dr.",name:"Antonio",middleName:null,surname:"Jurado-Navas",slug:"antonio-jurado-navas",fullName:"Antonio Jurado-Navas",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/55578/images/4574_n.png",biography:"Antonio Jurado-Navas received the M.S. degree (2002) and the Ph.D. degree (2009) in Telecommunication Engineering, both from the University of Málaga (Spain). He first worked as a consultant at Vodafone-Spain. From 2004 to 2011, he was a Research Assistant with the Communications Engineering Department at the University of Málaga. In 2011, he became an Assistant Professor in the same department. From 2012 to 2015, he was with Ericsson Spain, where he was working on geo-location\ntools for third generation mobile networks. Since 2015, he is a Marie-Curie fellow at the Denmark Technical University. His current research interests include the areas of mobile communication systems and channel modeling in addition to atmospheric optical communications, adaptive optics and statistics",institutionString:null,institution:{name:"University of Malaga",country:{name:"Spain"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:5774},{group:"region",caption:"Middle and South America",value:2,count:5239},{group:"region",caption:"Africa",value:3,count:1721},{group:"region",caption:"Asia",value:4,count:10411},{group:"region",caption:"Australia and Oceania",value:5,count:897},{group:"region",caption:"Europe",value:6,count:15810}],offset:12,limit:12,total:118377},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{hasNoEditors:"0",sort:"dateEndThirdStepPublish",topicId:"12"},books:[{type:"book",id:"10765",title:"Environmental Management",subtitle:null,isOpenForSubmission:!0,hash:"e5ba02fedd7c87f0ab66414f3b07de0c",slug:null,bookSignature:"Dr. John P. Tiefenbacher",coverURL:"https://cdn.intechopen.com/books/images_new/10765.jpg",editedByType:null,editors:[{id:"73876",title:"Dr.",name:"John P.",surname:"Tiefenbacher",slug:"john-p.-tiefenbacher",fullName:"John P. Tiefenbacher"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10763",title:"Biodiversity of Ecosystems",subtitle:null,isOpenForSubmission:!0,hash:"c96b42d4539957c58dfc2eb8fd9ffc21",slug:null,bookSignature:"Dr. Levente Hufnagel",coverURL:"https://cdn.intechopen.com/books/images_new/10763.jpg",editedByType:null,editors:[{id:"10864",title:"Dr.",name:"Levente",surname:"Hufnagel",slug:"levente-hufnagel",fullName:"Levente Hufnagel"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:18},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:5},{group:"topic",caption:"Business, Management and Economics",value:7,count:2},{group:"topic",caption:"Chemistry",value:8,count:8},{group:"topic",caption:"Computer and Information Science",value:9,count:6},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:7},{group:"topic",caption:"Engineering",value:11,count:20},{group:"topic",caption:"Environmental Sciences",value:12,count:2},{group:"topic",caption:"Immunology and Microbiology",value:13,count:4},{group:"topic",caption:"Materials Science",value:14,count:5},{group:"topic",caption:"Mathematics",value:15,count:1},{group:"topic",caption:"Medicine",value:16,count:25},{group:"topic",caption:"Neuroscience",value:18,count:2},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:3},{group:"topic",caption:"Physics",value:20,count:3},{group:"topic",caption:"Psychology",value:21,count:4},{group:"topic",caption:"Robotics",value:22,count:1},{group:"topic",caption:"Social Sciences",value:23,count:3},{group:"topic",caption:"Technology",value:24,count:1},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:1}],offset:12,limit:12,total:2},popularBooks:{featuredBooks:[{type:"book",id:"9521",title:"Antimicrobial Resistance",subtitle:"A One Health Perspective",isOpenForSubmission:!1,hash:"30949e78832e1afba5606634b52056ab",slug:"antimicrobial-resistance-a-one-health-perspective",bookSignature:"Mihai Mareș, Swee Hua Erin Lim, Kok-Song Lai and Romeo-Teodor Cristina",coverURL:"https://cdn.intechopen.com/books/images_new/9521.jpg",editors:[{id:"88785",title:"Prof.",name:"Mihai",middleName:null,surname:"Mares",slug:"mihai-mares",fullName:"Mihai Mares"}],equalEditorOne:{id:"190224",title:"Dr.",name:"Swee Hua Erin",middleName:null,surname:"Lim",slug:"swee-hua-erin-lim",fullName:"Swee Hua Erin Lim",profilePictureURL:"https://mts.intechopen.com/storage/users/190224/images/system/190224.png",biography:"Dr. Erin Lim is presently working as an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates and is affiliated as an Associate Professor to Perdana University-Royal College of Surgeons in Ireland, Selangor, Malaysia. She obtained her Ph.D. from Universiti Putra Malaysia in 2010 with a National Science Fellowship awarded from the Ministry of Science, Technology and Innovation Malaysia and has been actively involved in research ever since. Her main research interests include analysis of carriage and transmission of multidrug resistant bacteria in non-conventional settings, besides an interest in natural products for antimicrobial testing. She is heavily involved in the elucidation of mechanisms of reversal of resistance in bacteria in addition to investigating the immunological analyses of diseases, development of vaccination and treatment models in animals. She hopes her work will support the discovery of therapeutics in the clinical setting and assist in the combat against the burden of antibiotic resistance.",institutionString:"Abu Dhabi Women’s College",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Perdana University",institutionURL:null,country:{name:"Malaysia"}}},equalEditorTwo:{id:"221544",title:"Dr.",name:"Kok-Song",middleName:null,surname:"Lai",slug:"kok-song-lai",fullName:"Kok-Song Lai",profilePictureURL:"https://mts.intechopen.com/storage/users/221544/images/system/221544.jpeg",biography:"Dr. Lai Kok Song is an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates. He obtained his Ph.D. in Biological Sciences from Nara Institute of Science and Technology, Japan in 2012. Prior to his academic appointment, Dr. Lai worked as a Senior Scientist at the Ministry of Science, Technology and Innovation, Malaysia. His current research areas include antimicrobial resistance and plant-pathogen interaction. His particular interest lies in the study of the antimicrobial mechanism via membrane disruption of essential oils against multi-drug resistance bacteria through various biochemical, molecular and proteomic approaches. Ultimately, he hopes to uncover and determine novel biomarkers related to antibiotic resistance that can be developed into new therapeutic strategies.",institutionString:"Higher Colleges of Technology",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"8",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Higher Colleges of Technology",institutionURL:null,country:{name:"United Arab Emirates"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10020",title:"Operations Management",subtitle:"Emerging Trend in the Digital Era",isOpenForSubmission:!1,hash:"526f0dbdc7e4d85b82ce8383ab894b4c",slug:"operations-management-emerging-trend-in-the-digital-era",bookSignature:"Antonella Petrillo, Fabio De Felice, Germano Lambert-Torres and Erik Bonaldi",coverURL:"https://cdn.intechopen.com/books/images_new/10020.jpg",editors:[{id:"181603",title:"Dr.",name:"Antonella",middleName:null,surname:"Petrillo",slug:"antonella-petrillo",fullName:"Antonella Petrillo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9560",title:"Creativity",subtitle:"A Force to Innovation",isOpenForSubmission:!1,hash:"58f740bc17807d5d88d647c525857b11",slug:"creativity-a-force-to-innovation",bookSignature:"Pooja Jain",coverURL:"https://cdn.intechopen.com/books/images_new/9560.jpg",editors:[{id:"316765",title:"Dr.",name:"Pooja",middleName:null,surname:"Jain",slug:"pooja-jain",fullName:"Pooja Jain"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10192",title:"Background and Management of Muscular Atrophy",subtitle:null,isOpenForSubmission:!1,hash:"eca24028d89912b5efea56e179dff089",slug:"background-and-management-of-muscular-atrophy",bookSignature:"Julianna Cseri",coverURL:"https://cdn.intechopen.com/books/images_new/10192.jpg",editors:[{id:"135579",title:"Dr.",name:"Julianna",middleName:null,surname:"Cseri",slug:"julianna-cseri",fullName:"Julianna Cseri"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9243",title:"Coastal Environments",subtitle:null,isOpenForSubmission:!1,hash:"8e05e5f631e935eef366980f2e28295d",slug:"coastal-environments",bookSignature:"Yuanzhi Zhang and X. San Liang",coverURL:"https://cdn.intechopen.com/books/images_new/9243.jpg",editors:[{id:"77597",title:"Prof.",name:"Yuanzhi",middleName:null,surname:"Zhang",slug:"yuanzhi-zhang",fullName:"Yuanzhi Zhang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8985",title:"Natural Resources Management and Biological Sciences",subtitle:null,isOpenForSubmission:!1,hash:"5c2e219a6c021a40b5a20c041dea88c4",slug:"natural-resources-management-and-biological-sciences",bookSignature:"Edward R. Rhodes and Humood Naser",coverURL:"https://cdn.intechopen.com/books/images_new/8985.jpg",editors:[{id:"280886",title:"Prof.",name:"Edward R",middleName:null,surname:"Rhodes",slug:"edward-r-rhodes",fullName:"Edward R Rhodes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9644",title:"Glaciers and the Polar Environment",subtitle:null,isOpenForSubmission:!1,hash:"e8cfdc161794e3753ced54e6ff30873b",slug:"glaciers-and-the-polar-environment",bookSignature:"Masaki Kanao, Danilo Godone and Niccolò Dematteis",coverURL:"https://cdn.intechopen.com/books/images_new/9644.jpg",editors:[{id:"51959",title:"Dr.",name:"Masaki",middleName:null,surname:"Kanao",slug:"masaki-kanao",fullName:"Masaki Kanao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9550",title:"Entrepreneurship",subtitle:"Contemporary Issues",isOpenForSubmission:!1,hash:"9b4ac1ee5b743abf6f88495452b1e5e7",slug:"entrepreneurship-contemporary-issues",bookSignature:"Mladen Turuk",coverURL:"https://cdn.intechopen.com/books/images_new/9550.jpg",editors:[{id:"319755",title:"Prof.",name:"Mladen",middleName:null,surname:"Turuk",slug:"mladen-turuk",fullName:"Mladen Turuk"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9027",title:"Human Blood Group Systems and Haemoglobinopathies",subtitle:null,isOpenForSubmission:!1,hash:"d00d8e40b11cfb2547d1122866531c7e",slug:"human-blood-group-systems-and-haemoglobinopathies",bookSignature:"Osaro Erhabor and Anjana Munshi",coverURL:"https://cdn.intechopen.com/books/images_new/9027.jpg",editors:[{id:"35140",title:null,name:"Osaro",middleName:null,surname:"Erhabor",slug:"osaro-erhabor",fullName:"Osaro Erhabor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8558",title:"Aerodynamics",subtitle:null,isOpenForSubmission:!1,hash:"db7263fc198dfb539073ba0260a7f1aa",slug:"aerodynamics",bookSignature:"Mofid Gorji-Bandpy and Aly-Mousaad Aly",coverURL:"https://cdn.intechopen.com/books/images_new/8558.jpg",editors:[{id:"35542",title:"Prof.",name:"Mofid",middleName:null,surname:"Gorji-Bandpy",slug:"mofid-gorji-bandpy",fullName:"Mofid Gorji-Bandpy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:5249},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"9521",title:"Antimicrobial Resistance",subtitle:"A One Health Perspective",isOpenForSubmission:!1,hash:"30949e78832e1afba5606634b52056ab",slug:"antimicrobial-resistance-a-one-health-perspective",bookSignature:"Mihai Mareș, Swee Hua Erin Lim, Kok-Song Lai and Romeo-Teodor Cristina",coverURL:"https://cdn.intechopen.com/books/images_new/9521.jpg",editors:[{id:"88785",title:"Prof.",name:"Mihai",middleName:null,surname:"Mares",slug:"mihai-mares",fullName:"Mihai Mares"}],equalEditorOne:{id:"190224",title:"Dr.",name:"Swee Hua Erin",middleName:null,surname:"Lim",slug:"swee-hua-erin-lim",fullName:"Swee Hua Erin Lim",profilePictureURL:"https://mts.intechopen.com/storage/users/190224/images/system/190224.png",biography:"Dr. Erin Lim is presently working as an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates and is affiliated as an Associate Professor to Perdana University-Royal College of Surgeons in Ireland, Selangor, Malaysia. She obtained her Ph.D. from Universiti Putra Malaysia in 2010 with a National Science Fellowship awarded from the Ministry of Science, Technology and Innovation Malaysia and has been actively involved in research ever since. Her main research interests include analysis of carriage and transmission of multidrug resistant bacteria in non-conventional settings, besides an interest in natural products for antimicrobial testing. She is heavily involved in the elucidation of mechanisms of reversal of resistance in bacteria in addition to investigating the immunological analyses of diseases, development of vaccination and treatment models in animals. She hopes her work will support the discovery of therapeutics in the clinical setting and assist in the combat against the burden of antibiotic resistance.",institutionString:"Abu Dhabi Women’s College",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Perdana University",institutionURL:null,country:{name:"Malaysia"}}},equalEditorTwo:{id:"221544",title:"Dr.",name:"Kok-Song",middleName:null,surname:"Lai",slug:"kok-song-lai",fullName:"Kok-Song Lai",profilePictureURL:"https://mts.intechopen.com/storage/users/221544/images/system/221544.jpeg",biography:"Dr. Lai Kok Song is an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates. He obtained his Ph.D. in Biological Sciences from Nara Institute of Science and Technology, Japan in 2012. Prior to his academic appointment, Dr. Lai worked as a Senior Scientist at the Ministry of Science, Technology and Innovation, Malaysia. His current research areas include antimicrobial resistance and plant-pathogen interaction. His particular interest lies in the study of the antimicrobial mechanism via membrane disruption of essential oils against multi-drug resistance bacteria through various biochemical, molecular and proteomic approaches. Ultimately, he hopes to uncover and determine novel biomarkers related to antibiotic resistance that can be developed into new therapeutic strategies.",institutionString:"Higher Colleges of Technology",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"8",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Higher Colleges of Technology",institutionURL:null,country:{name:"United Arab Emirates"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10020",title:"Operations Management",subtitle:"Emerging Trend in the Digital Era",isOpenForSubmission:!1,hash:"526f0dbdc7e4d85b82ce8383ab894b4c",slug:"operations-management-emerging-trend-in-the-digital-era",bookSignature:"Antonella Petrillo, Fabio De Felice, Germano Lambert-Torres and Erik Bonaldi",coverURL:"https://cdn.intechopen.com/books/images_new/10020.jpg",editors:[{id:"181603",title:"Dr.",name:"Antonella",middleName:null,surname:"Petrillo",slug:"antonella-petrillo",fullName:"Antonella Petrillo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9560",title:"Creativity",subtitle:"A Force to Innovation",isOpenForSubmission:!1,hash:"58f740bc17807d5d88d647c525857b11",slug:"creativity-a-force-to-innovation",bookSignature:"Pooja Jain",coverURL:"https://cdn.intechopen.com/books/images_new/9560.jpg",editors:[{id:"316765",title:"Dr.",name:"Pooja",middleName:null,surname:"Jain",slug:"pooja-jain",fullName:"Pooja Jain"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10192",title:"Background and Management of Muscular Atrophy",subtitle:null,isOpenForSubmission:!1,hash:"eca24028d89912b5efea56e179dff089",slug:"background-and-management-of-muscular-atrophy",bookSignature:"Julianna Cseri",coverURL:"https://cdn.intechopen.com/books/images_new/10192.jpg",editors:[{id:"135579",title:"Dr.",name:"Julianna",middleName:null,surname:"Cseri",slug:"julianna-cseri",fullName:"Julianna Cseri"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9243",title:"Coastal Environments",subtitle:null,isOpenForSubmission:!1,hash:"8e05e5f631e935eef366980f2e28295d",slug:"coastal-environments",bookSignature:"Yuanzhi Zhang and X. San Liang",coverURL:"https://cdn.intechopen.com/books/images_new/9243.jpg",editors:[{id:"77597",title:"Prof.",name:"Yuanzhi",middleName:null,surname:"Zhang",slug:"yuanzhi-zhang",fullName:"Yuanzhi Zhang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8985",title:"Natural Resources Management and Biological Sciences",subtitle:null,isOpenForSubmission:!1,hash:"5c2e219a6c021a40b5a20c041dea88c4",slug:"natural-resources-management-and-biological-sciences",bookSignature:"Edward R. Rhodes and Humood Naser",coverURL:"https://cdn.intechopen.com/books/images_new/8985.jpg",editors:[{id:"280886",title:"Prof.",name:"Edward R",middleName:null,surname:"Rhodes",slug:"edward-r-rhodes",fullName:"Edward R Rhodes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9644",title:"Glaciers and the Polar Environment",subtitle:null,isOpenForSubmission:!1,hash:"e8cfdc161794e3753ced54e6ff30873b",slug:"glaciers-and-the-polar-environment",bookSignature:"Masaki Kanao, Danilo Godone and Niccolò Dematteis",coverURL:"https://cdn.intechopen.com/books/images_new/9644.jpg",editors:[{id:"51959",title:"Dr.",name:"Masaki",middleName:null,surname:"Kanao",slug:"masaki-kanao",fullName:"Masaki Kanao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9550",title:"Entrepreneurship",subtitle:"Contemporary Issues",isOpenForSubmission:!1,hash:"9b4ac1ee5b743abf6f88495452b1e5e7",slug:"entrepreneurship-contemporary-issues",bookSignature:"Mladen Turuk",coverURL:"https://cdn.intechopen.com/books/images_new/9550.jpg",editors:[{id:"319755",title:"Prof.",name:"Mladen",middleName:null,surname:"Turuk",slug:"mladen-turuk",fullName:"Mladen Turuk"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"9243",title:"Coastal Environments",subtitle:null,isOpenForSubmission:!1,hash:"8e05e5f631e935eef366980f2e28295d",slug:"coastal-environments",bookSignature:"Yuanzhi Zhang and X. San Liang",coverURL:"https://cdn.intechopen.com/books/images_new/9243.jpg",editedByType:"Edited by",editors:[{id:"77597",title:"Prof.",name:"Yuanzhi",middleName:null,surname:"Zhang",slug:"yuanzhi-zhang",fullName:"Yuanzhi Zhang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10020",title:"Operations Management",subtitle:"Emerging Trend in the Digital Era",isOpenForSubmission:!1,hash:"526f0dbdc7e4d85b82ce8383ab894b4c",slug:"operations-management-emerging-trend-in-the-digital-era",bookSignature:"Antonella Petrillo, Fabio De Felice, Germano Lambert-Torres and Erik Bonaldi",coverURL:"https://cdn.intechopen.com/books/images_new/10020.jpg",editedByType:"Edited by",editors:[{id:"181603",title:"Dr.",name:"Antonella",middleName:null,surname:"Petrillo",slug:"antonella-petrillo",fullName:"Antonella Petrillo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9521",title:"Antimicrobial Resistance",subtitle:"A One Health Perspective",isOpenForSubmission:!1,hash:"30949e78832e1afba5606634b52056ab",slug:"antimicrobial-resistance-a-one-health-perspective",bookSignature:"Mihai Mareș, Swee Hua Erin Lim, Kok-Song Lai and Romeo-Teodor Cristina",coverURL:"https://cdn.intechopen.com/books/images_new/9521.jpg",editedByType:"Edited by",editors:[{id:"88785",title:"Prof.",name:"Mihai",middleName:null,surname:"Mares",slug:"mihai-mares",fullName:"Mihai Mares"}],equalEditorOne:{id:"190224",title:"Dr.",name:"Swee Hua Erin",middleName:null,surname:"Lim",slug:"swee-hua-erin-lim",fullName:"Swee Hua Erin Lim",profilePictureURL:"https://mts.intechopen.com/storage/users/190224/images/system/190224.png",biography:"Dr. Erin Lim is presently working as an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates and is affiliated as an Associate Professor to Perdana University-Royal College of Surgeons in Ireland, Selangor, Malaysia. She obtained her Ph.D. from Universiti Putra Malaysia in 2010 with a National Science Fellowship awarded from the Ministry of Science, Technology and Innovation Malaysia and has been actively involved in research ever since. Her main research interests include analysis of carriage and transmission of multidrug resistant bacteria in non-conventional settings, besides an interest in natural products for antimicrobial testing. She is heavily involved in the elucidation of mechanisms of reversal of resistance in bacteria in addition to investigating the immunological analyses of diseases, development of vaccination and treatment models in animals. She hopes her work will support the discovery of therapeutics in the clinical setting and assist in the combat against the burden of antibiotic resistance.",institutionString:"Abu Dhabi Women’s College",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Perdana University",institutionURL:null,country:{name:"Malaysia"}}},equalEditorTwo:{id:"221544",title:"Dr.",name:"Kok-Song",middleName:null,surname:"Lai",slug:"kok-song-lai",fullName:"Kok-Song Lai",profilePictureURL:"https://mts.intechopen.com/storage/users/221544/images/system/221544.jpeg",biography:"Dr. Lai Kok Song is an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates. He obtained his Ph.D. in Biological Sciences from Nara Institute of Science and Technology, Japan in 2012. Prior to his academic appointment, Dr. Lai worked as a Senior Scientist at the Ministry of Science, Technology and Innovation, Malaysia. His current research areas include antimicrobial resistance and plant-pathogen interaction. His particular interest lies in the study of the antimicrobial mechanism via membrane disruption of essential oils against multi-drug resistance bacteria through various biochemical, molecular and proteomic approaches. Ultimately, he hopes to uncover and determine novel biomarkers related to antibiotic resistance that can be developed into new therapeutic strategies.",institutionString:"Higher Colleges of Technology",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"8",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Higher Colleges of Technology",institutionURL:null,country:{name:"United Arab Emirates"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9560",title:"Creativity",subtitle:"A Force to Innovation",isOpenForSubmission:!1,hash:"58f740bc17807d5d88d647c525857b11",slug:"creativity-a-force-to-innovation",bookSignature:"Pooja Jain",coverURL:"https://cdn.intechopen.com/books/images_new/9560.jpg",editedByType:"Edited by",editors:[{id:"316765",title:"Dr.",name:"Pooja",middleName:null,surname:"Jain",slug:"pooja-jain",fullName:"Pooja Jain"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9669",title:"Recent Advances in Rice Research",subtitle:null,isOpenForSubmission:!1,hash:"12b06cc73e89af1e104399321cc16a75",slug:"recent-advances-in-rice-research",bookSignature:"Mahmood-ur- Rahman Ansari",coverURL:"https://cdn.intechopen.com/books/images_new/9669.jpg",editedByType:"Edited by",editors:[{id:"185476",title:"Dr.",name:"Mahmood-Ur-",middleName:null,surname:"Rahman Ansari",slug:"mahmood-ur-rahman-ansari",fullName:"Mahmood-Ur- Rahman Ansari"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10192",title:"Background and Management of Muscular Atrophy",subtitle:null,isOpenForSubmission:!1,hash:"eca24028d89912b5efea56e179dff089",slug:"background-and-management-of-muscular-atrophy",bookSignature:"Julianna Cseri",coverURL:"https://cdn.intechopen.com/books/images_new/10192.jpg",editedByType:"Edited by",editors:[{id:"135579",title:"Dr.",name:"Julianna",middleName:null,surname:"Cseri",slug:"julianna-cseri",fullName:"Julianna Cseri"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9550",title:"Entrepreneurship",subtitle:"Contemporary Issues",isOpenForSubmission:!1,hash:"9b4ac1ee5b743abf6f88495452b1e5e7",slug:"entrepreneurship-contemporary-issues",bookSignature:"Mladen Turuk",coverURL:"https://cdn.intechopen.com/books/images_new/9550.jpg",editedByType:"Edited by",editors:[{id:"319755",title:"Prof.",name:"Mladen",middleName:null,surname:"Turuk",slug:"mladen-turuk",fullName:"Mladen Turuk"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editedByType:"Edited by",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9313",title:"Clay Science and Technology",subtitle:null,isOpenForSubmission:!1,hash:"6fa7e70396ff10620e032bb6cfa6fb72",slug:"clay-science-and-technology",bookSignature:"Gustavo Morari Do Nascimento",coverURL:"https://cdn.intechopen.com/books/images_new/9313.jpg",editedByType:"Edited by",editors:[{id:"7153",title:"Prof.",name:"Gustavo",middleName:null,surname:"Morari Do Nascimento",slug:"gustavo-morari-do-nascimento",fullName:"Gustavo Morari Do Nascimento"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9888",title:"Nuclear Power Plants",subtitle:"The Processes from the Cradle to the Grave",isOpenForSubmission:!1,hash:"c2c8773e586f62155ab8221ebb72a849",slug:"nuclear-power-plants-the-processes-from-the-cradle-to-the-grave",bookSignature:"Nasser Awwad",coverURL:"https://cdn.intechopen.com/books/images_new/9888.jpg",editedByType:"Edited by",editors:[{id:"145209",title:"Prof.",name:"Nasser",middleName:"S",surname:"Awwad",slug:"nasser-awwad",fullName:"Nasser Awwad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"331",title:"Forestry Science",slug:"agricultural-and-biological-sciences-ecology-forestry-science",parent:{title:"Ecology",slug:"agricultural-and-biological-sciences-ecology"},numberOfBooks:15,numberOfAuthorsAndEditors:463,numberOfWosCitations:373,numberOfCrossrefCitations:188,numberOfDimensionsCitations:496,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicSlug:"agricultural-and-biological-sciences-ecology-forestry-science",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"9720",title:"Advances in Forest Management under Global Change",subtitle:null,isOpenForSubmission:!1,hash:"df888eab42f96e1bd89b300edfaec25a",slug:"advances-in-forest-management-under-global-change",bookSignature:"Ling Zhang",coverURL:"https://cdn.intechopen.com/books/images_new/9720.jpg",editedByType:"Edited by",editors:[{id:"219350",title:"Dr.",name:"Ling",middleName:null,surname:"Zhang",slug:"ling-zhang",fullName:"Ling Zhang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9351",title:"Silvicultures",subtitle:"Management and Conservation",isOpenForSubmission:!1,hash:"f15a0f8b37429d28751d44f084e0ca69",slug:"silvicultures-management-and-conservation",bookSignature:"Fernando Allende Álvarez, Gillian Gomez-Mediavilla and Nieves López-Estébanez",coverURL:"https://cdn.intechopen.com/books/images_new/9351.jpg",editedByType:"Edited by",editors:[{id:"139581",title:"Dr.",name:"Fernando",middleName:null,surname:"Allende Álvarez",slug:"fernando-allende-alvarez",fullName:"Fernando Allende Álvarez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"4",chapterContentType:"compact",authoredCaption:"Authored by"}},{type:"book",id:"6264",title:"Forest Biomass and Carbon",subtitle:null,isOpenForSubmission:!1,hash:"964f96c9209ff2a3eaf3c5c6a54d81c3",slug:"forest-biomass-and-carbon",bookSignature:"Gopal Shukla and Sumit Chakravarty",coverURL:"https://cdn.intechopen.com/books/images_new/6264.jpg",editedByType:"Edited by",editors:[{id:"101105",title:"Dr.",name:"Gopal",middleName:null,surname:"Shukla",slug:"gopal-shukla",fullName:"Gopal Shukla"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6304",title:"Forest Fire",subtitle:null,isOpenForSubmission:!1,hash:"5d379ad4bcbaa4c9b702c13254a45f76",slug:"forest-fire",bookSignature:"Janusz Szmyt",coverURL:"https://cdn.intechopen.com/books/images_new/6304.jpg",editedByType:"Edited by",editors:[{id:"180608",title:"Dr.",name:"Janusz",middleName:null,surname:"Szmyt",slug:"janusz-szmyt",fullName:"Janusz Szmyt"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6162",title:"New Perspectives in Forest Science",subtitle:null,isOpenForSubmission:!1,hash:"514f8da8e59157028c3707db0deec202",slug:"new-perspectives-in-forest-science",bookSignature:"Helder Filipe dos Santos Viana and Francisco Antonio García Morote",coverURL:"https://cdn.intechopen.com/books/images_new/6162.jpg",editedByType:"Edited by",editors:[{id:"37172",title:"Prof.",name:"Helder",middleName:null,surname:"Viana",slug:"helder-viana",fullName:"Helder Viana"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5877",title:"Plant Ecology",subtitle:"Traditional Approaches to Recent Trends",isOpenForSubmission:!1,hash:"788a981ecedf0d9c0205869788524a80",slug:"plant-ecology-traditional-approaches-to-recent-trends",bookSignature:"Zubaida Yousaf",coverURL:"https://cdn.intechopen.com/books/images_new/5877.jpg",editedByType:"Edited by",editors:[{id:"196003",title:"Dr.",name:"Zubaida",middleName:null,surname:"Yousaf",slug:"zubaida-yousaf",fullName:"Zubaida Yousaf"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5988",title:"New Insights into Morphometry Studies",subtitle:null,isOpenForSubmission:!1,hash:"3c8701d62860a9cdfb6d09d9ffb32493",slug:"new-insights-into-morphometry-studies",bookSignature:"Pere M. Pares-Casanova",coverURL:"https://cdn.intechopen.com/books/images_new/5988.jpg",editedByType:"Edited by",editors:[{id:"199463",title:"Dr.",name:"Pere M.",middleName:null,surname:"Pares-Casanova",slug:"pere-m.-pares-casanova",fullName:"Pere M. Pares-Casanova"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5455",title:"Global Exposition of Wildlife Management",subtitle:null,isOpenForSubmission:!1,hash:"0c60fd890b4af7771afc5211fdabe762",slug:"global-exposition-of-wildlife-management",bookSignature:"Gbolagade Stephen A. Lameed",coverURL:"https://cdn.intechopen.com/books/images_new/5455.jpg",editedByType:"Edited by",editors:[{id:"142349",title:"Dr.",name:"Gbolagade Akeem",middleName:null,surname:"Lameed",slug:"gbolagade-akeem-lameed",fullName:"Gbolagade Akeem Lameed"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4757",title:"Precious Forests",subtitle:"Precious Earth",isOpenForSubmission:!1,hash:"6bd8329fb8128da2fc08c1c6d8a22613",slug:"precious-forests-precious-earth",bookSignature:"Miodrag Zlatic",coverURL:"https://cdn.intechopen.com/books/images_new/4757.jpg",editedByType:"Edited by",editors:[{id:"174414",title:"Dr.",name:"Miodrag",middleName:"Dusan",surname:"Zlatic",slug:"miodrag-zlatic",fullName:"Miodrag Zlatic"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"617",title:"Sustainable Forest Management",subtitle:"Current Research",isOpenForSubmission:!1,hash:"a8d91cf4745e90f7510e056fd508dc46",slug:"sustainable-forest-management-current-research",bookSignature:"Jorge Martin Garcia and Julio Javier Diez Casero",coverURL:"https://cdn.intechopen.com/books/images_new/617.jpg",editedByType:"Edited by",editors:[{id:"88987",title:"Dr.",name:"Julio J.",middleName:null,surname:"Diez",slug:"julio-j.-diez",fullName:"Julio J. Diez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1815",title:"New Advances and Contributions to Forestry Research",subtitle:null,isOpenForSubmission:!1,hash:"fb2caa8ab3683ea8aeba1810e7903a4a",slug:"new-advances-and-contributions-to-forestry-research",bookSignature:"Andrew Akwasi Oteng-Amoako",coverURL:"https://cdn.intechopen.com/books/images_new/1815.jpg",editedByType:"Edited by",editors:[{id:"119148",title:"Dr.",name:"Dr. Andrew A.",middleName:null,surname:"Oteng-Amoako",slug:"dr.-andrew-a.-oteng-amoako",fullName:"Dr. Andrew A. Oteng-Amoako"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2246",title:"Global Perspectives on Sustainable Forest Management",subtitle:null,isOpenForSubmission:!1,hash:"b633fc6fc6a3a8f24dd4c4373fb14cb7",slug:"global-perspectives-on-sustainable-forest-management",bookSignature:"Okia Clement Akais",coverURL:"https://cdn.intechopen.com/books/images_new/2246.jpg",editedByType:"Edited by",editors:[{id:"119660",title:"Dr.",name:"Dr. Clement A.",middleName:null,surname:"Okia",slug:"dr.-clement-a.-okia",fullName:"Dr. Clement A. Okia"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:15,mostCitedChapters:[{id:"36125",doi:"10.5772/33342",title:"Deforestation: Causes, Effects and Control Strategies",slug:"deforestation-causes-effects-and-control-strategies",totalDownloads:157148,totalCrossrefCites:23,totalDimensionsCites:67,book:{slug:"global-perspectives-on-sustainable-forest-management",title:"Global Perspectives on Sustainable Forest Management",fullTitle:"Global Perspectives on Sustainable Forest Management"},signatures:"Sumit Chakravarty, S. K. Ghosh, C. P. Suresh, A. N. Dey and Gopal Shukla",authors:[{id:"94999",title:"Dr.",name:"Sumit",middleName:null,surname:"Chakravarty",slug:"sumit-chakravarty",fullName:"Sumit Chakravarty"},{id:"101102",title:"Prof.",name:"Swapan Kr.",middleName:null,surname:"Ghosh",slug:"swapan-kr.-ghosh",fullName:"Swapan Kr. Ghosh"},{id:"101103",title:"Dr.",name:"C. P.",middleName:null,surname:"Suresh",slug:"c.-p.-suresh",fullName:"C. P. Suresh"},{id:"101104",title:"Dr.",name:"A N",middleName:null,surname:"Dey",slug:"a-n-dey",fullName:"A N Dey"},{id:"101105",title:"Dr.",name:"Gopal",middleName:null,surname:"Shukla",slug:"gopal-shukla",fullName:"Gopal Shukla"}]},{id:"30816",doi:"10.5772/30596",title:"Entomopathogenic Fungi as an Important Natural Regulator of Insect Outbreaks in Forests (Review)",slug:"entomopathogenic-fungi-as-an-important-natural-regulator-of-insect-outbreaks-in-forests-review-",totalDownloads:6086,totalCrossrefCites:6,totalDimensionsCites:26,book:{slug:"forest-ecosystems-more-than-just-trees",title:"Forest Ecosystems",fullTitle:"Forest Ecosystems - More than Just Trees"},signatures:"Anna Augustyniuk-Kram and Karol J. Kram",authors:[{id:"83229",title:"Dr.",name:"Karol",middleName:"J.",surname:"Kram",slug:"karol-kram",fullName:"Karol Kram"},{id:"87728",title:"Dr.",name:"Anna",middleName:null,surname:"Augustyniuk-Kram",slug:"anna-augustyniuk-kram",fullName:"Anna Augustyniuk-Kram"}]},{id:"36984",doi:"10.5772/29590",title:"Individual-Based Models and Scaling Methods for Ecological Forestry: Implications of Tree Phenotypic Plasticity",slug:"individual-based-models-and-scaling-methods-for-ecological-forestry-implications-of-tree-phenotypic-",totalDownloads:2172,totalCrossrefCites:3,totalDimensionsCites:19,book:{slug:"sustainable-forest-management-current-research",title:"Sustainable Forest Management",fullTitle:"Sustainable Forest Management - Current Research"},signatures:"Nikolay Strigul",authors:[{id:"78465",title:"Prof.",name:"Nikolay",middleName:null,surname:"Strigul",slug:"nikolay-strigul",fullName:"Nikolay Strigul"}]}],mostDownloadedChaptersLast30Days:[{id:"36125",title:"Deforestation: Causes, Effects and Control Strategies",slug:"deforestation-causes-effects-and-control-strategies",totalDownloads:157144,totalCrossrefCites:23,totalDimensionsCites:67,book:{slug:"global-perspectives-on-sustainable-forest-management",title:"Global Perspectives on Sustainable Forest Management",fullTitle:"Global Perspectives on Sustainable Forest Management"},signatures:"Sumit Chakravarty, S. K. Ghosh, C. P. Suresh, A. N. Dey and Gopal Shukla",authors:[{id:"94999",title:"Dr.",name:"Sumit",middleName:null,surname:"Chakravarty",slug:"sumit-chakravarty",fullName:"Sumit Chakravarty"},{id:"101102",title:"Prof.",name:"Swapan Kr.",middleName:null,surname:"Ghosh",slug:"swapan-kr.-ghosh",fullName:"Swapan Kr. Ghosh"},{id:"101103",title:"Dr.",name:"C. P.",middleName:null,surname:"Suresh",slug:"c.-p.-suresh",fullName:"C. P. Suresh"},{id:"101104",title:"Dr.",name:"A N",middleName:null,surname:"Dey",slug:"a-n-dey",fullName:"A N Dey"},{id:"101105",title:"Dr.",name:"Gopal",middleName:null,surname:"Shukla",slug:"gopal-shukla",fullName:"Gopal Shukla"}]},{id:"55309",title:"Plant-Microbe Ecology: Interactions of Plants and Symbiotic Microbial Communities",slug:"plant-microbe-ecology-interactions-of-plants-and-symbiotic-microbial-communities",totalDownloads:3689,totalCrossrefCites:8,totalDimensionsCites:16,book:{slug:"plant-ecology-traditional-approaches-to-recent-trends",title:"Plant Ecology",fullTitle:"Plant Ecology - Traditional Approaches to Recent Trends"},signatures:"Ying-Ning Ho, Dony Chacko Mathew and Chieh-Chen Huang",authors:[{id:"198872",title:"Dr.",name:"Ying-Ning",middleName:null,surname:"Ho",slug:"ying-ning-ho",fullName:"Ying-Ning Ho"},{id:"199676",title:"Prof.",name:"Chieh-Chen",middleName:null,surname:"Huang",slug:"chieh-chen-huang",fullName:"Chieh-Chen Huang"},{id:"201133",title:"Dr.",name:"Dony",middleName:"Chacko",surname:"Mathew",slug:"dony-mathew",fullName:"Dony Mathew"}]},{id:"48904",title:"Realities on Deforestation in Tanzania — Trends, Drivers, Implications and the Way Forward",slug:"realities-on-deforestation-in-tanzania-trends-drivers-implications-and-the-way-forward",totalDownloads:2831,totalCrossrefCites:3,totalDimensionsCites:11,book:{slug:"precious-forests-precious-earth",title:"Precious Forests",fullTitle:"Precious Forests - Precious Earth"},signatures:"Jafari R. Kideghesho",authors:[{id:"106119",title:"Prof.",name:"Jafari",middleName:"Ramadhani",surname:"Kideghesho",slug:"jafari-kideghesho",fullName:"Jafari Kideghesho"}]},{id:"52823",title:"Community Forestry Management and its Role in Biodiversity Conservation in Nepal",slug:"community-forestry-management-and-its-role-in-biodiversity-conservation-in-nepal",totalDownloads:2356,totalCrossrefCites:0,totalDimensionsCites:1,book:{slug:"global-exposition-of-wildlife-management",title:"Global Exposition of Wildlife Management",fullTitle:"Global Exposition of Wildlife Management"},signatures:"Anup K.C.",authors:[{id:"178579",title:"Mr.",name:"Anup",middleName:null,surname:"K.C.",slug:"anup-k.c.",fullName:"Anup K.C."}]},{id:"48930",title:"Creating Modern Community Conservation Organizations and Institutions to Effect Successful Forest Conservation Change",slug:"creating-modern-community-conservation-organizations-and-institutions-to-effect-successful-forest-co",totalDownloads:1333,totalCrossrefCites:2,totalDimensionsCites:6,book:{slug:"precious-forests-precious-earth",title:"Precious Forests",fullTitle:"Precious Forests - Precious Earth"},signatures:"Robert H. Horwich, Sam Shanee, Noga Shanee, Arnab Bose, Mark\nFenn and Joydeep Chakraborty",authors:[{id:"104422",title:"Dr.",name:"Robert",middleName:"H.",surname:"Horwich",slug:"robert-horwich",fullName:"Robert Horwich"}]},{id:"48637",title:"Forestry Entrepreneurs — Research on High Performance Business Model",slug:"forestry-entrepreneurs-research-on-high-performance-business-model",totalDownloads:4081,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"precious-forests-precious-earth",title:"Precious Forests",fullTitle:"Precious Forests - Precious Earth"},signatures:"Étienne St-Jean and Luc LeBel",authors:[{id:"104667",title:"Prof.",name:"Etienne",middleName:null,surname:"St-Jean",slug:"etienne-st-jean",fullName:"Etienne St-Jean"},{id:"104671",title:"Prof.",name:"Luc",middleName:null,surname:"LeBel",slug:"luc-lebel",fullName:"Luc LeBel"}]},{id:"57881",title:"Forest Fire Monitoring",slug:"forest-fire-monitoring",totalDownloads:1020,totalCrossrefCites:0,totalDimensionsCites:2,book:{slug:"forest-fire",title:"Forest Fire",fullTitle:"Forest Fire"},signatures:"Ahmad AA Alkhatib",authors:[{id:"215875",title:"Dr.",name:"Ahmad",middleName:null,surname:"Alkhatib",slug:"ahmad-alkhatib",fullName:"Ahmad Alkhatib"}]},{id:"55461",title:"MRI Morphometry of the Brain and Neurological Diseases",slug:"mri-morphometry-of-the-brain-and-neurological-diseases",totalDownloads:836,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"new-insights-into-morphometry-studies",title:"New Insights into Morphometry Studies",fullTitle:"New Insights into Morphometry Studies"},signatures:"Sergey Kotov",authors:[{id:"203592",title:"Prof.",name:"Sergey",middleName:null,surname:"Kotov",slug:"sergey-kotov",fullName:"Sergey Kotov"}]},{id:"34547",title:"Agroforestry Systems and Local Institutional Development for Preventing Deforestation in Chiapas, Mexico",slug:"agroforestry-systems-and-local-institutional-development-for-preventing-deforestation-in-chiapas-mex",totalDownloads:2832,totalCrossrefCites:0,totalDimensionsCites:7,book:{slug:"deforestation-around-the-world",title:"Deforestation Around the World",fullTitle:"Deforestation Around the World"},signatures:"Lorena Soto-Pinto, Miguel A. Castillo-Santiago and Guillermo Jiménez-Ferrer",authors:[{id:"103284",title:"Dr.",name:"Lorena",middleName:null,surname:"Soto-Pinto",slug:"lorena-soto-pinto",fullName:"Lorena Soto-Pinto"},{id:"105073",title:"Dr.",name:"Miguel A.",middleName:null,surname:"Castillo",slug:"miguel-a.-castillo",fullName:"Miguel A. Castillo"},{id:"105075",title:"Dr.",name:"Guillermo",middleName:null,surname:"Jimenez-Ferrer",slug:"guillermo-jimenez-ferrer",fullName:"Guillermo Jimenez-Ferrer"}]},{id:"58387",title:"Archetypes of Wildfire Arsonists: An Approach by Using Bayesian Networks",slug:"archetypes-of-wildfire-arsonists-an-approach-by-using-bayesian-networks",totalDownloads:608,totalCrossrefCites:1,totalDimensionsCites:1,book:{slug:"forest-fire",title:"Forest Fire",fullTitle:"Forest Fire"},signatures:"Rosario Delgado, José-Luis González, Andrés Sotoca and Xavier-\nAndoni Tibau",authors:[{id:"216927",title:"Dr.",name:"Rosario",middleName:null,surname:"Delgado",slug:"rosario-delgado",fullName:"Rosario Delgado"},{id:"216932",title:"Dr.",name:"José Luis",middleName:null,surname:"González",slug:"jose-luis-gonzalez",fullName:"José Luis González"},{id:"216933",title:"Dr.",name:"Andrés",middleName:null,surname:"Sotoca",slug:"andres-sotoca",fullName:"Andrés Sotoca"},{id:"216934",title:"MSc.",name:"Xavier Andoni",middleName:null,surname:"Tibau",slug:"xavier-andoni-tibau",fullName:"Xavier Andoni Tibau"}]}],onlineFirstChaptersFilter:{topicSlug:"agricultural-and-biological-sciences-ecology-forestry-science",limit:3,offset:0},onlineFirstChaptersCollection:[{id:"74831",title:"Ecology of the Seed Bank in the Amazon Rainforest",slug:"ecology-of-the-seed-bank-in-the-amazon-rainforest",totalDownloads:7,totalDimensionsCites:0,doi:"10.5772/intechopen.94745",book:{title:"Ecosystem and Biodiversity of Amazonia"},signatures:"Natali Gomes Bordon, Niwton Leal Filho and Tony Vizcarra Bentos"},{id:"75222",title:"Basic Theory and Methods of Afforestation",slug:"basic-theory-and-methods-of-afforestation",totalDownloads:34,totalDimensionsCites:0,doi:"10.5772/intechopen.96164",book:{title:"Silviculture"},signatures:"Jie Duan and Dilnur Abduwali"},{id:"74741",title:"Afforestation in Karst Area",slug:"afforestation-in-karst-area",totalDownloads:74,totalDimensionsCites:0,doi:"10.5772/intechopen.95294",book:{title:"Silviculture"},signatures:"Ninghua Zhu, Hai Shang, Liling Liu, Xiaowei Yang, Fei Liu and Shuangshuang Chen"}],onlineFirstChaptersTotal:19},preDownload:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[{type:"book",id:"10176",title:"Microgrids and Local Energy Systems",subtitle:null,isOpenForSubmission:!0,hash:"c32b4a5351a88f263074b0d0ca813a9c",slug:null,bookSignature:"Prof. Nick Jenkins",coverURL:"https://cdn.intechopen.com/books/images_new/10176.jpg",editedByType:null,editors:[{id:"55219",title:"Prof.",name:"Nick",middleName:null,surname:"Jenkins",slug:"nick-jenkins",fullName:"Nick Jenkins"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:8,limit:8,total:1},route:{name:"profile.detail",path:"/profiles/103567/ylanna-burgos",hash:"",query:{},params:{id:"103567",slug:"ylanna-burgos"},fullPath:"/profiles/103567/ylanna-burgos",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()